syndrome	score	normalized_score
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	100.0
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	99.99757978743851
SENGERS SYNDROME	1.00684932	98.97601022788514
OCULOSKELETODENTAL SYNDROME; OCSKD	1.002176874	98.51669615387331
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	98.30270355437608
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	98.30270355437608
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.0	98.30270355437608
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	91.74915721651648
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.546756484	53.747640563084964
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.5104167	50.17534154930291
BARTH SYNDROME; BTHS	0.50344828	49.490327023800525
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.50075643	49.22571089123768
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.500545554	49.20498121032295
GLYCINE ENCEPHALOPATHY	0.5	49.15135177718804
RENAL TUBULAR ACIDOSIS III	0.5	49.15135177718804
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	47.06610567804084
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.458151304	45.037511820162834
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3505744	34.462411316953265
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.34999969999999997	34.40591675322056
ACUTE ADRENAL INSUFFICIENCY	0.3470316	34.11414449880082
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33572074999999996	33.0022573643028
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.333878554	32.82116451702575
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333878554	32.82116451702575
EPIDERMAL NEVUS SYNDROME	0.333878554	32.82116451702575
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333333	32.76753508389084
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	32.76753508389084
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	32.76753508389084
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	32.76753508389084
NEUROMYELITIS OPTICA	0.333333	32.76753508389084
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	32.76753508389084
PLACENTAL INSUFFICIENCY	0.333333	32.76753508389084
ADDISON DISEASE	0.333333	32.76753508389084
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.32152769999999997	31.607042177620364
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	29.490811066312826
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27446538	26.98068888607918
HSD10 DISEASE	0.259060604	25.466357757629616
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.25661416000000004	25.225865698335237
BIOTINIDASE DEFICIENCY	0.250545554	24.629305321728925
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.250545554	24.629305321728925
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.250545554	24.629305321728925
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	24.57567588859402
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.25	24.57567588859402
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.23571430000000002	23.17135295642727
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.22272730000000002	21.89469574536659
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.21389157	21.02611959849008
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.20740741000000001	20.38870914021094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.207394874	20.387476817519183
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.20667832400000002	20.317038015287295
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20592189400000002	20.242678901237657
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20075643	19.734899824924852
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	19.714170144010122
SHOX-RELATED SHORT STATURE	0.2	19.660540710875217
POLYARTERITIS NODOSA	0.2	19.660540710875217
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	19.660540710875217
MEDULLARY SPONGE KIDNEY	0.2	19.660540710875217
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	19.660540710875217
BENIGN SCHWANNOMA	0.2	19.660540710875217
MALARIA	0.2	19.660540710875217
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	19.660540710875217
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	19.660540710875217
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	19.660540710875217
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.18039037400000002	17.73286145938503
MUCOLIPIDOSIS TYPE II	0.17570573	17.272348288995246
CEREBROOCULONASAL SYNDROME	0.16829832	16.544179859659526
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	16.3838166932972
DERMATOLEUKODYSTROPHY	0.166667	16.3838166932972
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	16.3838166932972
GITELMAN SYNDROME	0.14545450000000001	14.298570594149998
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.13837934999999998	13.603064221097249
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.13311061400000002	13.085133227982984
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1266234	12.447422553247184
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.1266234	12.447422553247184
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.1266234	12.447422553247184
PULMONARY ARTERIOVENOUS MALFORMATION	0.1266234	12.447422553247184
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.1266234	12.447422553247184
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1243902	12.227892955669553
OCULOCEREBRORENAL SYNDROME OF LOWE	0.12351602000000002	12.14195869827639
GALACTOSEMIA	0.12152769999999999	11.946501466745149
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	11.946501466745149
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	11.946501466745149
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11796991400000001	11.596761484277241
PYRUVATE CARBOXYLASE DEFICIENCY	0.114437124	11.249478676187378
ENTERIC ANENDOCRINOSIS	0.11111099999999999	10.92251169463028
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	10.92251169463028
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	10.92251169463028
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	10.854260127552479
FAMILIAL HYPOALDOSTERONISM	0.1104167	10.854260127552479
MELAS	0.10229164000000002	10.05554476301096
SAY SYNDROME	0.10075643000000001	9.904629469487245
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10054555400000001	9.883899788572514
RABSON-MENDENHALL SYNDROME	0.10054555400000001	9.883899788572514
X-LINKED ACROGIGANTISM	0.1	9.830270355437609
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	9.830270355437609
LOWE OCULOCEREBRORENAL SYNDROME	0.1	9.830270355437609
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	9.830270355437609
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	9.830270355437609
HUNTINGTON DISEASE-LIKE 1	0.09599150000000001	9.436223968239894
SALT-AND-PEPPER SYNDROME	0.09567534400000001	9.405144978694956
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.09512501000000001	9.35104565863706
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.09503851400000002	9.342542867990424
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.0945378	9.293321328082897
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.09449296000000001	9.288913434855518
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	9.172261548655682
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.09157110000000002	9.001686697448129
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.09152052399999999	8.996714939913161
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0910816	8.953567524058261
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.09092110400000002	8.9377903333486
MALIGNANT ATROPHIC PAPULOSIS	0.0909091	8.936610307695132
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0909091	8.936610307695132
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0909091	8.936610307695132
ARTERIAL TORTUOSITY SYNDROME	0.0909091	8.936610307695132
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09037555000000001	8.884160900213695
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.09037555000000001	8.884160900213695
HISTIOCYTOID CARDIOMYOPATHY	0.09037555000000001	8.884160900213695
ETHYLMALONIC ENCEPHALOPATHY	0.08827569	8.677738985128002
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08818919400000001	8.669236194481362
ADNP SYNDROME	0.08639898	8.493253318340468
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.08551017400000002	8.405881285605119
RFT1-CDG	0.08463528400000002	8.319877233292432
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.08463528400000002	8.319877233292432
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08463528400000002	8.319877233292432
BETA-KETOTHIOLASE DEFICIENCY	0.08393271999999999	8.25081329267245
PETTIGREW SYNDROME	0.08387885400000002	8.245518119242794
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.08387885400000002	8.245518119242794
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	8.19188868610789
STORMORKEN SYNDROME; STRMK	0.08333330000000001	8.19188868610789
SPEECH-LANGUAGE DISORDER 1	0.08333330000000001	8.19188868610789
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08333330000000001	8.19188868610789
RAVINE SYNDROME	0.08333330000000001	8.19188868610789
INHERITED CREUTZFELDT-JAKOB DISEASE	0.08333330000000001	8.19188868610789
DPM3-CDG	0.08333330000000001	8.19188868610789
TRISOMY 8P	0.07767953000000001	7.636107809833264
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.077628954	7.631136052298297
GLYCEROL KINASE DEFICIENCY; GKD	0.077628954	7.631136052298297
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	7.561748695783628
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	7.561748695783628
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	7.561748695783628
DDOST-CDG	0.07692310000000001	7.561748695783628
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	7.561748695783628
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	7.561748695783628
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	7.561748695783628
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	7.561748695783628
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	7.561748695783628
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07631254999999999	7.501729980128502
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.074254504	7.299418494289232
LYSOSOMAL ACID LIPASE DEFICIENCY	0.073067654	7.182747930575721
WOLCOTT-RALLISON SYNDROME	0.07250273	7.127214374072969
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07036015000000001	6.916592967491435
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.069686784	6.850399269209838
YOU-HOOVER-FONG SYNDROME; YHFS	0.069274384	6.809859234264014
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.067968684	6.681505394233064
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.067212254	6.607146280183428
XP21 MICRODELETION SYNDROME	0.067212254	6.607146280183428
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.067212254	6.607146280183428
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	6.553516847048524
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	6.553516847048524
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06623091	6.510677511866563
X-LINKED ADRENOLEUKODYSTROPHY	0.06605966	6.493843173882877
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.062686764	6.162278378275135
HUNTINGTON DISEASE-LIKE 2	0.06227178	6.121484329143325
VON HIPPEL-LINDAU DISEASE	0.06227178	6.121484329143325
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.061000373999999996	5.99650168202807
VICI SYNDROME; VICIS	0.060125484	5.910497629715382
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.060125484	5.910497629715382
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.060125484	5.910497629715382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059891624	5.887508559462155
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.05957993	5.8568681965804785
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.05957993	5.8568681965804785
BILATERAL POLYMICROGYRIA	0.059369054	5.836138515665745
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.059369054	5.836138515665745
ALAGILLE SYNDROME 1; ALGS1	0.0591531	5.814909653622364
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0588235	5.782509082530842
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	5.782509082530842
ACQUIRED METHEMOGLOBINEMIA	0.0588235	5.782509082530842
TIGLIC ACIDEMIA	0.0588235	5.782509082530842
3M SYNDROME	0.0588235	5.782509082530842
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	5.782509082530842
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	5.782509082530842
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	5.782509082530842
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.0588235	5.782509082530842
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.0588235	5.782509082530842
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	5.782509082530842
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0588235	5.782509082530842
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0588235	5.782509082530842
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.0588235	5.782509082530842
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	5.782509082530842
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	5.782509082530842
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	5.782509082530842
GAPO SYNDROME	0.0588235	5.782509082530842
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0588235	5.782509082530842
PSEUDOXANTHOMA ELASTICUM	0.0588235	5.782509082530842
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	5.782509082530842
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	5.782509082530842
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.0588235	5.782509082530842
BUTYRYLCHOLINESTERASE	0.0588235	5.782509082530842
ATYPICAL WERNER SYNDROME	0.0588235	5.782509082530842
MOYAMOYA DISEASE	0.0588235	5.782509082530842
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	5.782509082530842
WERNER SYNDROME	0.0588235	5.782509082530842
NOCARDIOSIS	0.0588235	5.782509082530842
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0588235	5.782509082530842
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	5.782509082530842
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0588235	5.782509082530842
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	5.782509082530842
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.05863523999999999	5.7640026155596935
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.058482054000000006	5.748944017613015
JUVENILE POLYPOSIS SYNDROME	0.0579365	5.69531458447811
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05776971000000001	5.678918676552276
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.057173184	5.6202785580117975
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.057173184	5.6202785580117975
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.057159714	5.61895442059492
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0566483	5.568681041759362
HYDROXYKYNURENINURIA	0.056416754	5.545919443962162
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05536529999999999	5.442558673099097
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05520688	5.426985558802014
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.05445045	5.352626444752377
KEARNS-SAYRE SYNDROME; KSS	0.053253180000000004	5.2349315668678305
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.053137430000000006	5.223553028931411
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.052826359999999996	5.19297400693675
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.05090785400000001	5.00437968035146
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.050362300000000006	4.950750247216555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.050310394	4.945647747085862
AICARDI SYNDROME	0.04983053999999999	4.898476801574478
ERYTHERMALGIA, PRIMARY	0.0494995	4.865934674589839
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.04907410999999999	4.824117687524842
AMISH INFANTILE EPILEPSY SYNDROME	0.04763039000000001	4.68219610834932
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.047141	4.634087748256843
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.047141	4.634087748256843
VICI SYNDROME	0.046000054	4.521929671847292
HAMAMY SYNDROME; HMMS	0.04597704	4.519667333427691
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04550946	4.4737029552997365
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	4.468300238712388
ALAGILLE SYNDROME 2	0.0454545	4.468300238712388
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	4.468300238712388
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0454545	4.468300238712388
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0454545	4.468300238712388
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	4.468300238712388
OSTEOPETROSIS AND RELATED DISORDERS	0.0454545	4.468300238712388
XQ12-Q13.3 DUPLICATION SYNDROME	0.044054449999999995	4.330671538601083
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814000000001	4.313339788937412
49,XXXYY SYNDROME	0.04329801999999999	4.256312424551446
HYDROXYKYNURENINURIA	0.043220353999999996	4.2486776467771925
LISSENCEPHALY, X-LINKED, 2	0.04312171000000001	4.238980674887776
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.042555699999999995	4.183340361648962
XP22.13P22.2 DUPLICATION SYNDROME	0.042423129999999996	4.170308372238758
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.042423129999999996	4.170308372238758
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	4.170308372238758
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042423129999999996	4.170308372238758
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042423129999999996	4.170308372238758
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042423129999999996	4.170308372238758
NON-DISTAL MONOSOMY 20Q	0.042053259999999995	4.1339491512751
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	4.095949258189122
HISTIDINEMIA	0.041666699999999994	4.095949258189122
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.041666699999999994	4.095949258189122
PGM3-CDG	0.041666699999999994	4.095949258189122
49,XYYYY SYNDROME	0.041666699999999994	4.095949258189122
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.041655960000000006	4.094893487152949
ACRORENAL-MANDIBULAR SYNDROME	0.04102532	4.032899870183416
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.04042194	3.9735859849127775
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.04042194	3.9735859849127775
NEURONAL CEROID LIPOFUSCINOSIS	0.04035632	3.9671353615055387
FABRY DISEASE	0.04002464000000001	3.934530320790624
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	3.9290312675537913
WILLIAMS-BEUREN SYNDROME; WBS	0.03972012	3.9045951815042446
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.03916258	3.849787492164538
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.03916258	3.849787492164538
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.038888900000000004	3.8228840082557767
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.038647604	3.7991639590989195
ZELLWEGER SYNDROME	0.038102050000000005	3.7455345259640156
OCULOECTODERMAL SYNDROME; OES	0.037891174	3.7248048450492823
VASCULAR EHLERS-DANLOS SYNDROME	0.037891174	3.7248048450492823
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03763444	3.6995671987549534
OCULODENTODIGITAL DYSPLASIA	0.037337699999999995	3.6703968545022274
ATYPICAL RETT SYNDROME	0.03732487	3.6691356308156253
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.037324869999999996	3.6691356308156253
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.037016284	3.638800792736595
PYRIDOXINE-DEPENDENT EPILEPSY	0.036591533999999995	3.597046719401873
HUNTINGTON DISEASE	0.03656844	3.5947765167659886
FLYNN-AIRD SYNDROME	0.03656844	3.5947765167659886
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03647073000000001	3.585171359601691
MICROHYDRANENCEPHALY; MHAC	0.03647073000000001	3.585171359601691
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03647073000000001	3.585171359601691
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03647073000000001	3.585171359601691
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	3.543417286266969
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	3.543417286266969
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.036002320000000004	3.5391253902297857
BRAIN-LUNG-THYROID SYNDROME	0.035784784	3.5177410133093807
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.035714300000000004	3.5108122455520543
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.035714300000000004	3.5108122455520543
SCHINZEL-GIEDION SYNDROME	0.035714300000000004	3.5108122455520543
FAMILIAL THROMBOCYTOSIS	0.035714300000000004	3.5108122455520543
FAMILIAL CERVICAL ARTERY DISSECTION	0.035714300000000004	3.5108122455520543
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	3.5108122455520543
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.035714300000000004	3.5108122455520543
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	3.5108122455520543
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	3.5108122455520543
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	3.5108122455520543
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.035714300000000004	3.5108122455520543
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.035714300000000004	3.5108122455520543
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	3.5108122455520543
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.035714300000000004	3.5108122455520543
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.035714300000000004	3.5108122455520543
SLC39A8-CDG	0.035714300000000004	3.5108122455520543
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.035714300000000004	3.5108122455520543
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.035714300000000004	3.5108122455520543
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	3.5108122455520543
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.035714300000000004	3.5108122455520543
SPINOCEREBELLAR ATAXIA TYPE 34	0.035706379999999996	3.510033688139903
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.035191404	3.459410155074285
WOLF-HIRSCHHORN SYNDROME	0.035191404	3.459410155074285
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.035028354	3.443381899259743
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	3.3897524661248393
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.0344828	3.3897524661248393
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	3.3897524661248393
BECKER MUSCULAR DYSTROPHY	0.0344828	3.3897524661248393
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.0344828	3.3897524661248393
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0344828	3.3897524661248393
RICHIERI COSTA-DA SILVA SYNDROME	0.0344828	3.3897524661248393
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	3.3897524661248393
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	3.3897524661248393
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	3.3897524661248393
LENNOX-GASTAUT SYNDROME	0.0344828	3.3897524661248393
FRIEDREICH ATAXIA	0.0344828	3.3897524661248393
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.0344828	3.3897524661248393
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.0344828	3.3897524661248393
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0344828	3.3897524661248393
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0344828	3.3897524661248393
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	3.3897524661248393
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	3.3897524661248393
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	3.3897524661248393
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0344828	3.3897524661248393
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	3.3897524661248393
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	3.3897524661248393
GIANT AXONAL NEUROPATHY	0.0344828	3.3897524661248393
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.033889419999999996	3.3314216078897436
9P13 MICRODELETION SYNDROME	0.033889419999999996	3.3314216078897436
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033889419999999996	3.3314216078897436
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.033560084	3.2990469887119596
MEIER-GORLIN SYNDROME 5; MGORS5	0.03301453	3.2454175555770557
ISOTRETINOIN-LIKE SYNDROME	0.03301453	3.2454175555770557
ISOLATED CEREBELLAR AGENESIS	0.03301453	3.2454175555770557
SECKEL SYNDROME	0.03301453	3.2454175555770557
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.03301453	3.2454175555770557
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.03301453	3.2454175555770557
SECKEL SYNDROME 2; SCKL2	0.03301453	3.2454175555770557
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	3.224687874662323
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	3.224687874662323
GRISCELLI SYNDROME TYPE 1	0.032803653999999995	3.224687874662323
SARCOSINEMIA	0.032803653999999995	3.224687874662323
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.032803653999999995	3.224687874662323
OXOGLUTARIC ACIDURIA	0.032803653999999995	3.224687874662323
NETHERTON SYNDROME; NETH	0.032803653999999995	3.224687874662323
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	3.224687874662323
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	3.224687874662323
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.032541504000000006	3.1989178209255438
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	3.171058441527419
INFANTILE MYOFIBROMATOSIS	0.0322581	3.171058441527419
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	3.171058441527419
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0322581	3.171058441527419
DENT DISEASE	0.0322581	3.171058441527419
ROWLEY-ROSENBERG SYNDROME	0.0322581	3.171058441527419
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	3.171058441527419
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	3.171058441527419
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	3.171058441527419
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	3.171058441527419
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	3.171058441527419
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	3.171058441527419
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	3.171058441527419
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	3.171058441527419
THROMBOCYTOPENIA 1	0.0322581	3.171058441527419
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	3.171058441527419
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	3.171058441527419
SANDHOFF DISEASE	0.0322581	3.171058441527419
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	3.171058441527419
DIENCEPHALIC SYNDROME	0.0322581	3.171058441527419
MILD CANAVAN DISEASE	0.0322581	3.171058441527419
COG1-CDG	0.0322581	3.171058441527419
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0322581	3.171058441527419
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	3.171058441527419
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	3.171058441527419
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	3.171058441527419
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	3.171058441527419
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	3.171058441527419
LESCH-NYHAN SYNDROME	0.0322581	3.171058441527419
DESMOID TUMOR	0.0322581	3.171058441527419
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	3.171058441527419
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	3.171058441527419
LEIGH SYNDROME	0.0322581	3.171058441527419
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	3.171058441527419
DEND SYNDROME	0.0322581	3.171058441527419
CONGENITAL ANALBUMINEMIA	0.0322581	3.171058441527419
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	3.171058441527419
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	3.171058441527419
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	3.171058441527419
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	3.171058441527419
DYSTONIA, JUVENILE-ONSET	0.0322581	3.171058441527419
MERRF	0.0322581	3.171058441527419
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.030531844	3.0013628097004563
AL KAISSI SYNDROME; ALKAS	0.030531844	3.0013628097004563
COFFIN-LOWRY SYNDROME	0.029910139999999998	2.940247625689886
TRISOMY 20P	0.0294698	2.8969610132067523
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.02937504	2.88764584901794
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.02926445	2.8767745530318614
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.029058534	2.8565324535267584
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.028900524	2.8409996433381313
DRAVET SYNDROME	0.02870054	2.8213406754705126
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.02870054	2.8213406754705126
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.028407544	2.7925383765398952
SPINOCEREBELLAR ATAXIA TYPE 5	0.027838480000000002	2.7365978468444276
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.026972464	2.651466132723081
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.026567074	2.6116151997291723
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.026567074	2.6116151997291723
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.026216034	2.577107018673444
DOWN SYNDROME	0.02605664	2.561438157543098
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.025692184	2.5256111474164844
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.025692184	2.5256111474164844
FETAL HYDANTOIN SYNDROME	0.025660603999999997	2.522506748038237
PHELAN-MCDERMID SYNDROME	0.025155504	2.4728540524729214
PITT-HOPKINS SYNDROME	0.02514663	2.47198171428158
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.024935754	2.4512520333668477
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.024935754	2.4512520333668477
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.024935754	2.4512520333668477
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.024935754	2.4512520333668477
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.024935754	2.4512520333668477
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.024935754	2.4512520333668477
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.024935754	2.4512520333668477
SPINOCEREBELLAR ATAXIA 5; SCA5	0.024935754	2.4512520333668477
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.024935754	2.4512520333668477
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.024853824	2.443198092864638
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.024853824	2.443198092864638
MAN1B1-CDG	0.024399074	2.3984949384232848
CHROMOSOME 17P13.1 DELETION SYNDROME	0.024399074	2.3984949384232848
ADRENOLEUKODYSTROPHY	0.0243902	2.3976226002319434
HUNTINGTON DISEASE-LIKE 1	0.0243902	2.3976226002319434
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0243902	2.3976226002319434
EPISODIC ATAXIA, TYPE 1; EA1	0.0243902	2.3976226002319434
SPINOCEREBELLAR ATAXIA 26	0.0243902	2.3976226002319434
SPINOCEREBELLAR ATAXIA TYPE 6	0.0243902	2.3976226002319434
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0243902	2.3976226002319434
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0243902	2.3976226002319434
ORAL SENSIBILITY, DISTURBANCE OF	0.0243902	2.3976226002319434
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0243902	2.3976226002319434
MILLER-DIEKER SYNDROME	0.024358619999999997	2.394518200853696
CRANIOFACIOFRONTODIGITAL SYNDROME	0.024358619999999997	2.394518200853696
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	2.3895686597297336
PRIMARY HYPEROXALURIA TYPE 1	0.0241153	2.3705991870248457
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.024061574	2.365317775973683
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024029283999999998	2.362143581675912
POTOCKI-LUPSKI SYNDROME	0.024029283999999998	2.362143581675912
SCARF SYNDROME	0.02385352	2.344865505288381
COFFIN-SIRIS SYNDROME 1; CSS1	0.023524184	2.3124908861105973
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.023524184	2.3124908861105973
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.023524184	2.3124908861105973
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.023524184	2.3124908861105973
KAGAMI-OGATA SYNDROME	0.023272854	2.2877844676262757
SILVER-RUSSELL SYNDROME; SRS	0.023272854	2.2877844676262757
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.02297863	2.258861452975693
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.02297863	2.258861452975693
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.02297863	2.258861452975693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.02297863	2.258861452975693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.02297863	2.258861452975693
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02297863	2.258861452975693
2Q23.1 MICRODUPLICATION SYNDROME	0.022767754	2.2381317720609606
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.022767754	2.2381317720609606
TYSHCHENKO SYNDROME	0.022767754	2.2381317720609606
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.022767754	2.2381317720609606
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.022767754	2.2381317720609606
CHROMOSOME 5Q12 DELETION SYNDROME	0.022767754	2.2381317720609606
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.022767754	2.2381317720609606
YUNIS-VARON SYNDROME	0.022767754	2.2381317720609606
FG SYNDROME TYPE 1	0.022767754	2.2381317720609606
ARTERIES, ANOMALIES OF	0.0227273	2.2341550344913714
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	2.2341550344913714
ATROPHODERMA VERMICULATA; AVA	0.0227273	2.2341550344913714
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	2.2341550344913714
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	2.2341550344913714
FATCO SYNDROME	0.0227273	2.2341550344913714
MUSCULAR HYPERTONIA, LETHAL	0.0227273	2.2341550344913714
SILVER-RUSSELL SYNDROME	0.0227273	2.2341550344913714
LARSEN SYNDROME	0.0227273	2.2341550344913714
PREPAPILLARY VASCULAR LOOPS	0.0227273	2.2341550344913714
COWDEN SYNDROME 6; CWS6	0.0227273	2.2341550344913714
BETHLEM MYOPATHY 1	0.0227273	2.2341550344913714
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	2.2341550344913714
WATSON SYNDROME	0.0227273	2.2341550344913714
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	2.2341550344913714
CONGENITAL ATRANSFERRINEMIA	0.0227273	2.2341550344913714
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	2.2341550344913714
COWDEN SYNDROME 5; CWS5	0.0227273	2.2341550344913714
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	2.2341550344913714
COCAINE EMBRYOFETOPATHY	0.0227273	2.2341550344913714
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	2.2341550344913714
AMYLOIDOSIS	0.0227273	2.2341550344913714
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	2.2341550344913714
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	2.2341550344913714
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	2.2341550344913714
THUMB DEFORMITY	0.0227273	2.2341550344913714
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	2.2341550344913714
SIRENOMELIA	0.0227273	2.2341550344913714
RHOMBENCEPHALOSYNAPSIS	0.0227273	2.2341550344913714
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	2.2341550344913714
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02252572	2.21433917550888
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.022314844	2.193609494594148
RAPADILINO SYNDROME	0.0222222	2.1845023389260563
SMITH-KINGSMORE SYNDROME; SKS	0.0222222	2.1845023389260563
JUVENILE POLYPOSIS OF INFANCY	0.0222222	2.1845023389260563
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0222222	2.1845023389260563
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0222222	2.1845023389260563
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0222222	2.1845023389260563
FRONTOMETAPHYSEAL DYSPLASIA	0.0222222	2.1845023389260563
ALG13-CDG	0.0222222	2.1845023389260563
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0222222	2.1845023389260563
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.022195744	2.1819016426008213
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.022195744	2.1819016426008213
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.02204304	2.1668904265572544
UNILATERAL POLYMICROGYRIA	0.021862439999999997	2.1491369582953332
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	2.06723507780197
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	2.06723507780197
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	2.06723507780197
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	2.06723507780197
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	2.06723507780197
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.02075642	2.0404122021101228
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.020740849999999998	2.038881629015781
WILLIAMS SYNDROME	0.020396689999999995	2.0050497705605066
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.020392254	2.0046136997675394
KOOLEN-DE VRIES SYNDROME; KDVS	0.019600003999999997	1.9267333828765851
TRISOMY 18	0.019600003999999997	1.9267333828765851
DOORS SYNDROME	0.019600003999999997	1.9267333828765851
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.019600003999999997	1.9267333828765851
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01950752	1.9176419556410627
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01950752	1.9176419556410627
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.019503893999999997	1.9172855100379742
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.019503893999999997	1.9172855100379742
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.019481839999999997	1.9151175422137858
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.019054449999999997	1.873103949741681
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.018897340000000002	1.8576596119862534
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018843574	1.8523742688269487
FUMARASE DEFICIENCY; FMRD	0.018760934	1.8442505334052153
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.018760934	1.8442505334052153
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.018747464	1.8429263959883375
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.018747464	1.8429263959883375
AMISH LETHAL MICROCEPHALY	0.01858054	1.826517315500227
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.018580094000000002	1.8264734724944418
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.018568004	1.8252849928084693
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.018567069999999998	1.8251931780833495
CEREBROOCULONASAL SYNDROME	0.018298019999999998	1.7987448356920444
NASODIGITOACOUSTIC SYNDROME	0.018298019999999998	1.7987448356920444
COSTELLO SYNDROME	0.018298019999999998	1.7987448356920444
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.018298019999999998	1.7987448356920444
SAETHRE-CHOTZEN SYNDROME	0.018298019999999998	1.7987448356920444
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.018298019999999998	1.7987448356920444
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.018201909999999998	1.7892969628534334
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.018175320000000002	1.7866830939659228
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.01802245	1.7716555596735653
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.01802245	1.7716555596735653
PROPIONIC ACIDEMIA	0.018004504	1.7698914193555786
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.018004504	1.7698914193555786
BOHRING-OPITZ SYNDROME	0.017968684	1.7663702165142605
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.017968684	1.7663702165142605
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017968684	1.7663702165142605
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.017811574	1.7509258787588329
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.017811574	1.7509258787588329
PEARSON SYNDROME	0.01745895	1.7162619862206745
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.01745895	1.7162619862206745
COLCHICINE POISONING	0.01745895	1.7162619862206745
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.01745895	1.7162619862206745
COFFIN-LOWRY SYNDROME; CLS	0.01742313	1.7127407833793562
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.01742313	1.7127407833793562
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01726602	1.6972964456239286
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	1.6972964456239286
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.01726602	1.6972964456239286
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.01726602	1.6972964456239286
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01726602	1.6972964456239286
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.01726602	1.6972964456239286
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.6948762330624196
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.6948762330624196
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.6948762330624196
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.6948762330624196
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.6948762330624196
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.6948762330624196
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.6948762330624196
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.6948762330624196
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.6948762330624196
MOTION SICKNESS	0.0172414	1.6948762330624196
DIASTEMATOMYELIA	0.0172414	1.6948762330624196
ALCOHOL DEPENDENCE	0.0172414	1.6948762330624196
TRANSSEXUALITY	0.0172414	1.6948762330624196
THUMBS, CONGENITAL CLASPED	0.0172414	1.6948762330624196
JUMPING FRENCHMAN OF MAINE	0.0172414	1.6948762330624196
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.6948762330624196
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.6948762330624196
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.6948762330624196
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.6948762330624196
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.6948762330624196
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.6948762330624196
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.6948762330624196
SICKLE CELL ANEMIA	0.0172414	1.6948762330624196
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.6948762330624196
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.6948762330624196
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.6948762330624196
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.6948762330624196
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.6948762330624196
269800 SENILE PLAQUE FORMATION	0.0172414	1.6948762330624196
PALMOMENTAL REFLEX	0.0172414	1.6948762330624196
MOSAIC TRISOMY 15	0.0172414	1.6948762330624196
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.6948762330624196
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.6948762330624196
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.6948762330624196
RHEUMATOID ARTHRITIS	0.0172414	1.6948762330624196
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.6948762330624196
CERVICAL RIB	0.0172414	1.6948762330624196
CARDIAC ARRHYTHMIA	0.0172414	1.6948762330624196
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.6948762330624196
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.6948762330624196
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.6948762330624196
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.6948762330624196
MYOPATHY, CONGENITAL	0.0172414	1.6948762330624196
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.6948762330624196
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.6948762330624196
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.017212254	1.6920111024646238
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.017212254	1.6920111024646238
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.017212254	1.6920111024646238
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.017212254	1.6920111024646238
ALPHA-MANNOSIDOSIS	0.017212254	1.6920111024646238
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01714688	1.6855846615224601
ABETA AMYLOIDOSIS, IOWA TYPE	0.01714688	1.6855846615224601
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.01696854	1.668053357370573
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.01696854	1.668053357370573
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.01696854	1.668053357370573
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0166667	1.63838166932972
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.0166667	1.63838166932972
MARFAN SYNDROME; MFS	0.0166667	1.63838166932972
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0166667	1.63838166932972
WARBURG MICRO SYNDROME 3; WARBM3	0.0166667	1.63838166932972
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0166667	1.63838166932972
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0166667	1.63838166932972
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0166667	1.63838166932972
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0166667	1.63838166932972
BÖÖK SYNDROME	0.0166667	1.63838166932972
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0166667	1.63838166932972
PYCNODYSOSTOSIS	0.0166667	1.63838166932972
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0166667	1.63838166932972
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0166667	1.63838166932972
CROUZON DISEASE	0.0166667	1.63838166932972
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0166667	1.63838166932972
APERT SYNDROME	0.0166667	1.63838166932972
RAMON SYNDROME	0.0166667	1.63838166932972
RAMON SYNDROME	0.0166667	1.63838166932972
PYCNODYSOSTOSIS	0.0166667	1.63838166932972
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.016106480000000003	1.5833105287444877
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.016106480000000003	1.5833105287444877
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.016068443999999998	1.5795714871120927
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.015558714	1.5294636500293208
NEONATAL ADRENOLEUKODYSTROPHY	0.01550563	1.5242453493138404
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.015346424000000001	1.5085949690917624
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.015272594	1.501337280488343
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.015193554	1.493567434799405
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.015193554	1.493567434799405
CEDNIK SYNDROME	0.015000583999999999	1.4745979620945169
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.015000583999999999	1.4745979620945169
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.015000583999999999	1.4745979620945169
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.01472704	1.4477078473534388
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.014648	1.4399380016645007
LEIGH SYNDROME; LS	0.014437123999999999	1.419208320749768
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014437123999999999	1.419208320749768
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.014437123999999999	1.419208320749768
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.014437123999999999	1.419208320749768
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.014437123999999999	1.419208320749768
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.014437123999999999	1.419208320749768
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.014437123999999999	1.419208320749768
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014437123999999999	1.419208320749768
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.014437123999999999	1.419208320749768
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.014437123999999999	1.419208320749768
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.014437123999999999	1.419208320749768
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.014437123999999999	1.419208320749768
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014437123999999999	1.419208320749768
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01441507	1.41704035292558
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.014256729999999999	1.40147510284478
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014244153999999998	1.4002388480448802
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.014244153999999998	1.4002388480448802
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.014244153999999998	1.4002388480448802
ABETAL34V AMYLOIDOSIS	0.014244153999999998	1.4002388480448802
CITRULLINEMIA, CLASSIC	0.014244153999999998	1.4002388480448802
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.013960184000000002	1.3723238293165443
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.013891569999999999	1.365578887614864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	1.365578887614864
LIVER FAILURE, INFANTILE, TRANSIENT	0.013891569999999999	1.365578887614864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.013891569999999999	1.365578887614864
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.013891569999999999	1.365578887614864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013891569999999999	1.365578887614864
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	1.365578887614864
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013891569999999999	1.365578887614864
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.013891569999999999	1.365578887614864
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.013698599999999998	1.346609414909976
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.013698599999999998	1.346609414909976
STROKE, ISCHEMIC	0.013698599999999998	1.346609414909976
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	1.346609414909976
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	1.346609414909976
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	1.346609414909976
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	1.346609414909976
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.013698599999999998	1.346609414909976
SICKLE CELL ANEMIA	0.013698599999999998	1.346609414909976
ACYS AMYLOIDOSIS	0.013698599999999998	1.346609414909976
ABETA AMYLOIDOSIS, DUTCH TYPE	0.013698599999999998	1.346609414909976
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	1.346609414909976
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	1.346609414909976
EISENMENGER SYNDROME	0.013698599999999998	1.346609414909976
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	1.346609414909976
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.013698599999999998	1.346609414909976
POLYCYTHEMIA VERA	0.013698599999999998	1.346609414909976
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013698599999999998	1.346609414909976
PRADER-WILLI SYNDROME	0.013698599999999998	1.346609414909976
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	1.346609414909976
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	1.346609414909976
AORTA COARCTATION	0.013698599999999998	1.346609414909976
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.013698599999999998	1.346609414909976
WALDENSTRÖM MACROGLOBULINEMIA	0.013698599999999998	1.346609414909976
SNEDDON SYNDROME	0.013698599999999998	1.346609414909976
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	1.346609414909976
FAMILIAL AORTIC DISSECTION	0.013698599999999998	1.346609414909976
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.013698599999999998	1.346609414909976
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	1.346609414909976
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	1.346609414909976
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	1.346609414909976
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.013698599999999998	1.346609414909976
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	1.346609414909976
SECONDARY POLYCYTHEMIA	0.013698599999999998	1.346609414909976
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013698599999999998	1.346609414909976
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	1.346609414909976
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	1.346609414909976
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	1.346609414909976
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	1.346609414909976
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.013698599999999998	1.346609414909976
AMYLOIDOSIS VI	0.013698599999999998	1.346609414909976
STURGE-WEBER SYNDROME	0.013698599999999998	1.346609414909976
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	1.346609414909976
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	1.346609414909976
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01354018	1.331036300612892
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.013414630000000002	1.3186943961816402
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.013414630000000002	1.3186943961816402
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.013414630000000002	1.3186943961816402
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.013350004000000002	1.3123414856617353
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.013203754000000002	1.2979647152669076
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.013203754000000002	1.2979647152669076
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.013203754000000002	1.2979647152669076
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.013203754000000002	1.2979647152669076
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.013203754000000002	1.2979647152669076
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.013134960000000001	1.2912020790785879
8P INVERTED DUPLICATION/DELETION SYNDROME	0.01278375	1.2566771865632553
4Q21 MICRODELETION SYNDROME	0.01278375	1.2566771865632553
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.012658200000000001	1.2443352821320035
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.012658200000000001	1.2443352821320035
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.012658200000000001	1.2443352821320035
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.012658200000000001	1.2443352821320035
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.012658200000000001	1.2443352821320035
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012658200000000001	1.2443352821320035
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.012658200000000001	1.2443352821320035
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.012658200000000001	1.2443352821320035
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.012658200000000001	1.2443352821320035
MULTIPLE SYSTEM ATROPHY	0.012658200000000001	1.2443352821320035
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.012658200000000001	1.2443352821320035
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.012658200000000001	1.2443352821320035
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.012658200000000001	1.2443352821320035
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.012658200000000001	1.2443352821320035
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.012658200000000001	1.2443352821320035
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	1.2443352821320035
SPINOCEREBELLAR ATAXIA 37; SCA37	0.012658200000000001	1.2443352821320035
SPINOCEREBELLAR ATAXIA 44; SCA44	0.012658200000000001	1.2443352821320035
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.012658200000000001	1.2443352821320035
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.012658200000000001	1.2443352821320035
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.012658200000000001	1.2443352821320035
STIFF-PERSON SYNDROME; SPS	0.012658200000000001	1.2443352821320035
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.012658200000000001	1.2443352821320035
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.012658200000000001	1.2443352821320035
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.012658200000000001	1.2443352821320035
CAP MYOPATHY	0.012658200000000001	1.2443352821320035
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.012658200000000001	1.2443352821320035
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	1.2443352821320035
NEMALINE MYOPATHY 3; NEM3	0.012658200000000001	1.2443352821320035
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.012658200000000001	1.2443352821320035
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.012658200000000001	1.2443352821320035
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.012658200000000001	1.2443352821320035
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	1.2443352821320035
EPISODIC ATAXIA TYPE 4	0.012658200000000001	1.2443352821320035
PRIMARY PROGRESSIVE FREEZING GAIT	0.012658200000000001	1.2443352821320035
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.012658200000000001	1.2443352821320035
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.012658200000000001	1.2443352821320035
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.012658200000000001	1.2443352821320035
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.012658200000000001	1.2443352821320035
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.012658200000000001	1.2443352821320035
HYPEREKPLEXIA 1; HKPX1	0.012658200000000001	1.2443352821320035
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.012658200000000001	1.2443352821320035
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.012658200000000001	1.2443352821320035
X-LINKED DYSTONIA-PARKINSONISM	0.012658200000000001	1.2443352821320035
NEMALINE MYOPATHY 2; NEM2	0.012658200000000001	1.2443352821320035
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.012658200000000001	1.2443352821320035
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.012658200000000001	1.2443352821320035
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.012658200000000001	1.2443352821320035
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.012658200000000001	1.2443352821320035
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.012658200000000001	1.2443352821320035
MYOPATHY AND DIABETES MELLITUS	0.012658200000000001	1.2443352821320035
PURE MITOCHONDRIAL MYOPATHY	0.012658200000000001	1.2443352821320035
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.012658200000000001	1.2443352821320035
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.012654574	1.243978836528915
TRISOMY XQ28	0.01248701	1.2275068423105298
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01247418	1.226245618623927
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01247418	1.226245618623927
CHRISTIANSON SYNDROME	0.01247418	1.226245618623927
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012461644000000001	1.2250132959321696
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012461644000000001	1.2250132959321696
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.012461644000000001	1.2250132959321696
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.01210902	1.190349403394011
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.01195172	1.1748863881249076
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01195172	1.1748863881249076
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.01191609	1.1713838627972655
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01191609	1.1713838627972655
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.011898144	1.1696197224792784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.011898144	1.1696197224792784
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.011898144	1.1696197224792784
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.011757924000000001	1.1558357173868838
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.011718684000000002	1.1519783192994104
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.011718684000000002	1.1519783192994104
COG8-CDG	0.011717749999999999	1.1518865045742903
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.011717749999999999	1.1518865045742903
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.011717749999999999	1.1518865045742903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.011717749999999999	1.1518865045742903
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.011705214	1.1506541818825327
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.011705214	1.1506541818825327
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.011705214	1.1506541818825327
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.011705214	1.1506541818825327
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.01161212	1.1415027899978416
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.01135259	1.1159902893443743
DILATED CARDIOMYOPATHY WITH ATAXIA	0.01115966	1.0970247487476286
KLEEFSTRA SYNDROME	0.010988664	1.0802153796506446
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010962254000000001	1.0776192052497735
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010962254000000001	1.0776192052497735
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.010962254000000001	1.0776192052497735
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010962254000000001	1.0776192052497735
METHYLMALONIC ACIDURIA, CBLB TYPE	0.010962254000000001	1.0776192052497735
ISOVALERIC ACIDEMIA	0.010962254000000001	1.0776192052497735
MICROVILLUS INCLUSION DISEASE	0.010962254000000001	1.0776192052497735
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010962254000000001	1.0776192052497735
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010962254000000001	1.0776192052497735
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010962254000000001	1.0776192052497735
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.010962254000000001	1.0776192052497735
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.010843154	1.0659113532564473
NON-DISTAL MONOSOMY 10Q	0.01045594	1.027847170202343
HEREDITARY FRUCTOSE INTOLERANCE	0.010416700000000001	1.0239897721148694
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010416700000000001	1.0239897721148694
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010416700000000001	1.0239897721148694
PRIMARY HYPEROXALURIA	0.010416700000000001	1.0239897721148694
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	1.0239897721148694
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.010416700000000001	1.0239897721148694
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	1.0239897721148694
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.010416700000000001	1.0239897721148694
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	1.0239897721148694
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	1.0239897721148694
SUDDEN CARDIAC FAILURE, INFANTILE	0.010416700000000001	1.0239897721148694
RIBOFLAVIN DEFICIENCY	0.010416700000000001	1.0239897721148694
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	1.0239897721148694
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010416700000000001	1.0239897721148694
NEUROLEPTIC MALIGNANT SYNDROME	0.010416700000000001	1.0239897721148694
HAWKINSINURIA	0.010416700000000001	1.0239897721148694
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.010416700000000001	1.0239897721148694
HAWKINSINURIA	0.010416700000000001	1.0239897721148694
GLUTARIC ACIDEMIA I; GA1	0.010416700000000001	1.0239897721148694
SMITH-MAGENIS SYNDROME	0.010126604	0.9954725510245591
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009935494000000001	0.9766859213482825
MONOSOMY 5P	0.00979516	0.9628907097476824
HALL-RIGGS SYNDROME	0.00979516	0.9628907097476824
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00979516	0.9628907097476824
TEMPLE-BARAITSER SYNDROME	0.00979516	0.9628907097476824
RING CHROMOSOME 7 SYNDROME	0.00979516	0.9628907097476824
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00968668	0.9522268324661036
EPILEPSY-TELANGIECTASIA	0.00916422	0.9008676019670845
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.00903873	0.8885315956980457
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.8885315956980457
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00903873	0.8885315956980457
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00903873	0.8885315956980457
CRANIOFACIAL DYSSYNOSTOSIS	0.00903873	0.8885315956980457
ASPARTYLGLUCOSAMINURIA; AGU	0.00885465	0.8704360340277563
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00882462	0.8674840038400182
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00882462	0.8674840038400182
PIERPONT SYNDROME	0.008709394	0.8561569765202618
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008709394	0.8561569765202618
ADENYLOSUCCINASE DEFICIENCY	0.008709394	0.8561569765202618
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008709394	0.8561569765202618
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.008643774	0.8497063531130236
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008538144000000001	0.839322638536575
PELIZAEUS-MERZBACHER DISEASE	0.008515050000000001	0.8370524359006901
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.008515050000000001	0.8370524359006901
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.008344234	0.8202607612903458
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.008344234	0.8202607612903458
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.008344234	0.8202607612903458
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.008344234	0.8202607612903458
ISOLATED COMPLEX I DEFICIENCY	0.008344234	0.8202607612903458
INFANTILE LIVER FAILURE SYNDROME 1	0.008344234	0.8202607612903458
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008309644000000001	0.8168604707744
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.008309644000000001	0.8168604707744
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.008309644000000001	0.8168604707744
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.008309644000000001	0.8168604707744
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.008309644000000001	0.8168604707744
BARATELA-SCOTT SYNDROME	0.008309644000000001	0.8168604707744
HOLOPROSENCEPHALY	0.008309644000000001	0.8168604707744
17Q21.31 MICRODUPLICATION SYNDROME	0.008309644000000001	0.8168604707744
DESBUQUOIS DYSPLASIA 2; DBQD2	0.008309644000000001	0.8168604707744
1Q44 MICRODELETION SYNDROME	0.008309644000000001	0.8168604707744
FETAL TRIMETHADIONE SYNDROME	0.008309644000000001	0.8168604707744
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.008309644000000001	0.8168604707744
CHROMOSOME 1P36 DELETION SYNDROME	0.008309644000000001	0.8168604707744
19P13.12 MICRODELETION SYNDROME	0.008309644000000001	0.8168604707744
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.008309644000000001	0.8168604707744
MONOSOMY 9P	0.008309644000000001	0.8168604707744
2Q31.1 MICRODELETION SYNDROME	0.008309644000000001	0.8168604707744
HYPERMANGANESEMIA WITH DYSTONIA 2	0.008304174000000001	0.8163227549859575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.008304174000000001	0.8163227549859575
NIEMANN-PICK DISEASE TYPE C	0.008304174000000001	0.8163227549859575
DISTAL MONOSOMY 10P	0.00816384	0.8025275433853576
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00816384	0.8025275433853576
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00816384	0.8025275433853576
SECKEL SYNDROME 7; SCKL7	0.00816384	0.8025275433853576
ALLAN-HERNDON-DUDLEY SYNDROME	0.00816384	0.8025275433853576
KEPPEN-LUBINSKY SYNDROME	0.00816384	0.8025275433853576
YUNIS-VARON SYNDROME	0.00816384	0.8025275433853576
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00816384	0.8025275433853576
CROME SYNDROME	0.00816384	0.8025275433853576
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.8025275433853576
COFS SYNDROME	0.00816384	0.8025275433853576
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00816384	0.8025275433853576
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00816384	0.8025275433853576
MEHMO SYNDROME	0.00816384	0.8025275433853576
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00816384	0.8025275433853576
HENNEKAM-BEEMER SYNDROME	0.00816384	0.8025275433853576
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00816384	0.8025275433853576
LOWRY-MACLEAN SYNDROME	0.00816384	0.8025275433853576
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.8025275433853576
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00816384	0.8025275433853576
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00816384	0.8025275433853576
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00816384	0.8025275433853576
HEREDITARY METHEMOGLOBINEMIA	0.00816384	0.8025275433853576
DPM1-CDG	0.00816384	0.8025275433853576
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00816384	0.8025275433853576
BOWEN-CONRADI SYNDROME	0.00816384	0.8025275433853576
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.008151304	0.8012952206935999
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.008151304	0.8012952206935999
REFSUM DISEASE	0.00809822	0.7960769199781195
300270 ADRENOMYODYSTROPHY	0.007952964	0.781797862470625
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.781797862470625
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.781797862470625
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.781797862470625
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.781797862470625
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.781797862470625
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007952964	0.781797862470625
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00779868	0.7666313281554417
PSEUDO-TORCH SYNDROME 2	0.00779868	0.7666313281554417
3-HYDROXYISOBUTYRIC ACIDURIA	0.00779868	0.7666313281554417
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00779868	0.7666313281554417
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00779868	0.7666313281554417
MONOSOMY 22	0.00776409	0.7632310376394958
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00776409	0.7632310376394958
DUPLICATION/INVERSION 15Q11	0.00776409	0.7632310376394958
WIEDEMANN-STEINER SYNDROME	0.00776409	0.7632310376394958
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00776409	0.7632310376394958
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00776409	0.7632310376394958
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00776409	0.7632310376394958
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00776409	0.7632310376394958
ALEXANDER DISEASE	0.007758620000000001	0.7626933218510534
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.007758620000000001	0.7626933218510534
FAMILIAL COLORECTAL CANCER TYPE X	0.007758620000000001	0.7626933218510534
METACHROMATIC LEUKODYSTROPHY	0.007758620000000001	0.7626933218510534
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007758620000000001	0.7626933218510534
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.007758620000000001	0.7626933218510534
LYNCH SYNDROME	0.007758620000000001	0.7626933218510534
CHOREOACANTHOCYTOSIS	0.007758620000000001	0.7626933218510534
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.007758620000000001	0.7626933218510534
CADASIL	0.007758620000000001	0.7626933218510534
ATAXIA WITH VITAMIN E DEFICIENCY	0.007758620000000001	0.7626933218510534
BEHÇET DISEASE	0.007758620000000001	0.7626933218510534
NEUROFERRITINOPATHY	0.007758620000000001	0.7626933218510534
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.007587804	0.7459016472407091
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.007587804	0.7459016472407091
NAVAJO NEUROHEPATOPATHY	0.007587804	0.7459016472407091
HYPOTONIA-CYSTINURIA SYNDROME	0.007587804	0.7459016472407091
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.007587804	0.7459016472407091
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.007587804	0.7459016472407091
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.007587804	0.7459016472407091
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.007587804	0.7459016472407091
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007587804	0.7459016472407091
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.007587804	0.7459016472407091
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.007587804	0.7459016472407091
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.007587804	0.7459016472407091
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.007587804	0.7459016472407091
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007587804	0.7459016472407091
2P21 MICRODELETION SYNDROME	0.007587804	0.7459016472407091
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.007587804	0.7459016472407091
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007587804	0.7459016472407091
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.007587804	0.7459016472407091
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.007553214000000001	0.7425013567247633
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007553214000000001	0.7425013567247633
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.007553214000000001	0.7425013567247633
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.007553214000000001	0.7425013567247633
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.007553214000000001	0.7425013567247633
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007553214000000001	0.7425013567247633
2Q24 MICRODELETION SYNDROME	0.00740741	0.7281684293357209
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.7281684293357209
LISSENCEPHALY 5; LIS5	0.00740741	0.7281684293357209
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.7281684293357209
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.7281684293357209
GABRIELE-DE VRIES SYNDROME	0.00740741	0.7281684293357209
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00740741	0.7281684293357209
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.7281684293357209
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00740741	0.7281684293357209
FRYNS SYNDROME	0.00740741	0.7281684293357209
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00740741	0.7281684293357209
ADRENOMYODYSTROPHY	0.00740741	0.7281684293357209
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00740741	0.7281684293357209
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.7281684293357209
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.7281684293357209
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00740741	0.7281684293357209
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00740741	0.7281684293357209
SMITH-FINEMAN-MYERS SYNDROME	0.00740741	0.7281684293357209
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.7281684293357209
KID SYNDROME	0.00740741	0.7281684293357209
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00740741	0.7281684293357209
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.7281684293357209
PITT-HOPKINS-LIKE SYNDROME	0.00740741	0.7281684293357209
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.7281684293357209
1Q41Q42 MICRODELETION SYNDROME	0.00740741	0.7281684293357209
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.7281684293357209
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.7281684293357209
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.7281684293357209
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00740741	0.7281684293357209
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.7281684293357209
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.7281684293357209
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.7281684293357209
QAZI-MARKOUIZOS SYNDROME	0.00740741	0.7281684293357209
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.7281684293357209
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.7281684293357209
TRISOMY 13	0.00740741	0.7281684293357209
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.7281684293357209
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.7281684293357209
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00740741	0.7281684293357209
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.7281684293357209
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00740741	0.7281684293357209
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.7281684293357209
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007394874	0.7269361066439632
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007394874	0.7269361066439632
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007394874	0.7269361066439632
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.007394874	0.7269361066439632
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.007394874	0.7269361066439632
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.007394874	0.7269361066439632
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.007394874	0.7269361066439632
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007394874	0.7269361066439632
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.007394874	0.7269361066439632
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007394874	0.7269361066439632
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.007394874	0.7269361066439632
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.007394874	0.7269361066439632
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.007394874	0.7269361066439632
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007394874	0.7269361066439632
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.007243644	0.7120697887854349
WITTEVEEN-KOLK SYNDROME	0.007243644	0.7120697887854349
RING CHROMOSOME 22 SYNDROME	0.007243644	0.7120697887854349
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00723616	0.7113340913520341
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00723616	0.7113340913520341
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00723616	0.7113340913520341
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00723616	0.7113340913520341
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.692272214105805
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.692272214105805
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00704225	0.692272214105805
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.692272214105805
MAPLE SYRUP URINE DISEASE; MSUD	0.00704225	0.692272214105805
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00704225	0.692272214105805
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.692272214105805
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.692272214105805
GLYCOGEN STORAGE DISEASE IXC	0.00704225	0.692272214105805
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.692272214105805
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00704225	0.692272214105805
GRACILE SYNDROME	0.00704225	0.692272214105805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00704225	0.692272214105805
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00704225	0.692272214105805
SUCCINIC ACIDEMIA	0.00704225	0.692272214105805
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00704225	0.692272214105805
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.692272214105805
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.692272214105805
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00704225	0.692272214105805
GLYCOGEN STORAGE DISEASE IB	0.00704225	0.692272214105805
GLYCOGEN STORAGE DISEASE IA	0.00704225	0.692272214105805
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00704225	0.692272214105805
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00704225	0.692272214105805
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007007660000000001	0.6888719235898592
LICHTENSTEIN SYNDROME	0.007007660000000001	0.6888719235898592
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.007007660000000001	0.6888719235898592
FOUNTAIN SYNDROME	0.007007660000000001	0.6888719235898592
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.007007660000000001	0.6888719235898592
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.007007660000000001	0.6888719235898592
CEREBROFACIOTHORACIC DYSPLASIA	0.007007660000000001	0.6888719235898592
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.007007660000000001	0.6888719235898592
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.007007660000000001	0.6888719235898592
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.6733066735090592
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.6733066735090592
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.6733066735090592
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.6733066735090592
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00684932	0.6733066735090592
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.6733066735090592
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.6733066735090592
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.6733066735090592
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00684932	0.6733066735090592
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.6733066735090592
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.6733066735090592
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.6733066735090592
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.6733066735090592
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00684932	0.6733066735090592
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00684932	0.6733066735090592
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.6733066735090592
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00684932	0.6733066735090592
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.6733066735090592
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.6733066735090592
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00684932	0.6733066735090592
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.6733066735090592
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00684932	0.6733066735090592
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.6733066735090592
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00684932	0.6733066735090592
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.6733066735090592
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.6733066735090592
BARAITSER-WINTER SYNDROME 1; BRWS1	0.006721183999999999	0.6607105582864156
CHROMOSOME 10Q26 DELETION SYNDROME	0.006721183999999999	0.6607105582864156
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.006721183999999999	0.6607105582864156
14Q12 MICRODELETION SYNDROME	0.006698089999999999	0.6584403556505308
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.006678324	0.6564973044120751
HOLOPROSENCEPHALY 11	0.006678324	0.6564973044120751
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.006678324	0.6564973044120751
ALAZAMI-YUAN SYNDROME	0.006678324	0.6564973044120751
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.006678324	0.6564973044120751
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006678324	0.6564973044120751
KBG SYNDROME	0.006678324	0.6564973044120751
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006678324	0.6564973044120751
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.006678324	0.6564973044120751
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006678324	0.6564973044120751
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.006678324	0.6564973044120751
GOLDBERG-SHPRINTZEN SYNDROME	0.006678324	0.6564973044120751
BOHRING-OPITZ SYNDROME	0.006678324	0.6564973044120751
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006678324	0.6564973044120751
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.006678324	0.6564973044120751
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.006678324	0.6564973044120751
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.006678324	0.6564973044120751
HOLOPROSENCEPHALY 5; HPE5	0.006678324	0.6564973044120751
12Q14 MICRODELETION SYNDROME	0.006678324	0.6564973044120751
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006487214	0.6377106747357982
2P15P16.1 MICRODELETION SYNDROME	0.006381584	0.6273269601593495
PYRUVATE DEHYDROGENASE DEFICIENCY	0.006381584	0.6273269601593495
1P36 DELETION SYNDROME	0.006381584	0.6273269601593495
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00617563	0.6070811251515116
2Q23.1 MICRODELETION SYNDROME	0.00613277	0.602867871277171
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00613277	0.602867871277171
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00613277	0.602867871277171
CORNELIA DE LANGE SYNDROME 1	0.00613277	0.602867871277171
BRANCHIOSKELETOGENITAL SYNDROME	0.00613277	0.602867871277171
NON-DISTAL TRISOMY 13Q	0.00613277	0.602867871277171
FONTAINE PROGEROID SYNDROME; FPS	0.00613277	0.602867871277171
9Q SUBTELOMERIC DELETION SYNDROME	0.00613277	0.602867871277171
CORNELIA DE LANGE SYNDROME	0.00613277	0.602867871277171
20P13 MICRODELETION SYNDROME	0.00613277	0.602867871277171
PIEBALDISM	0.00613277	0.602867871277171
MICROTRIPLICATION 11Q24.1	0.00613277	0.602867871277171
XYLT1-CDG	0.00613277	0.602867871277171
KLEEFSTRA SYNDROME	0.00613277	0.602867871277171
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00613277	0.602867871277171
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00613277	0.602867871277171
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00613277	0.602867871277171
CUTIS LAXA	0.005964753999999999	0.5863514442367789
CORNELIA DE LANGE SYNDROME 3	0.0059218940000000005	0.5821381903624384
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0059218940000000005	0.5821381903624384
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0059218940000000005	0.5821381903624384
DESANTO-SHINAWI SYNDROME	0.0059218940000000005	0.5821381903624384
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0059218940000000005	0.5821381903624384
SMITH-MAGENIS SYNDROME; SMS	0.0059218940000000005	0.5821381903624384
ELSAHY-WATERS SYNDROME; ESWS	0.0059218940000000005	0.5821381903624384
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0059218940000000005	0.5821381903624384
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0059218940000000005	0.5821381903624384
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0059218940000000005	0.5821381903624384
EVEN-PLUS SYNDROME	0.0059218940000000005	0.5821381903624384
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0059218940000000005	0.5821381903624384
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.5821381903624384
GERMAN SYNDROME	0.0059218940000000005	0.5821381903624384
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0059218940000000005	0.5821381903624384
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.5821381903624384
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0059218940000000005	0.5821381903624384
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0059218940000000005	0.5821381903624384
11P15.4 MICRODUPLICATION SYNDROME	0.0059218940000000005	0.5821381903624384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0059218940000000005	0.5821381903624384
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00583603	0.5736975270244454
TETRASOMY 18P	0.00583603	0.5736975270244454
OROFACIODIGITAL SYNDROME TYPE 6	0.005625154	0.552967846109713
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.005625154	0.552967846109713
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.005625154	0.552967846109713
COHEN-GIBSON SYNDROME; COGIS	0.005625154	0.552967846109713
ALPERS-HUTTENLOCHER SYNDROME	0.005612324	0.5517066224231102
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005612324	0.5517066224231102
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.005612324	0.5517066224231102
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005612324	0.5517066224231102
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.005612324	0.5517066224231102
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.005612324	0.5517066224231102
AICARDI-GOUTIERES SYNDROME 7	0.005612324	0.5517066224231102
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.005612324	0.5517066224231102
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.005612324	0.5517066224231102
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.005612324	0.5517066224231102
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005612324	0.5517066224231102
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005612324	0.5517066224231102
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005612324	0.5517066224231102
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.005612324	0.5517066224231102
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005612324	0.5517066224231102
AICARDI-GOUTIÈRES SYNDROME	0.005612324	0.5517066224231102
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005612324	0.5517066224231102
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.005612324	0.5517066224231102
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005612324	0.5517066224231102
AICARDI-GOUTIERES SYNDROME 6	0.005612324	0.5517066224231102
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.005612324	0.5517066224231102
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.005612324	0.5517066224231102
MULTIPLE SULFATASE DEFICIENCY	0.005612324	0.5517066224231102
EHLERS-DANLOS SYNDROME, TYPE VI	0.0054192	0.5327220111018749
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00537634	0.5285087572275343
WAARDENBURG-SHAH SYNDROME	0.00537634	0.5285087572275343
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.5285087572275343
WAARDENBURG SYNDROME TYPE 1	0.00537634	0.5285087572275343
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.5285087572275343
MCDONOUGH SYNDROME	0.00537634	0.5285087572275343
MCDONOUGH SYNDROME	0.00537634	0.5285087572275343
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.5285087572275343
SOMATOMAMMOTROPINOMA	0.00537634	0.5285087572275343
17Q24.2 MICRODELETION SYNDROME	0.00537634	0.5285087572275343
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00537634	0.5285087572275343
MARSHALL-SMITH SYNDROME; MRSHSS	0.00537634	0.5285087572275343
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.5285087572275343
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00537634	0.5285087572275343
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.5285087572275343
17Q12 MICRODUPLICATION SYNDROME	0.00537634	0.5285087572275343
ZLOTOGORA-OGUR SYNDROME	0.00537634	0.5285087572275343
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00537634	0.5285087572275343
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.5285087572275343
ZIMMERMANN-LABAND SYNDROME 1	0.00537634	0.5285087572275343
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00537634	0.5285087572275343
ACROMEGALY	0.00537634	0.5285087572275343
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00537634	0.5285087572275343
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00537634	0.5285087572275343
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00537634	0.5285087572275343
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.5285087572275343
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.5285087572275343
MENTAL RETARDATION, X-LINKED 21	0.00537634	0.5285087572275343
GASTROCUTANEOUS SYNDROME	0.00537634	0.5285087572275343
TRANSALDOLASE DEFICIENCY	0.00537634	0.5285087572275343
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00537634	0.5285087572275343
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00537634	0.5285087572275343
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00537634	0.5285087572275343
WAARDENBURG SYNDROME	0.00537634	0.5285087572275343
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00537634	0.5285087572275343
ACROOSTEOLYSIS DOMINANT TYPE	0.00537634	0.5285087572275343
PRIMROSE SYNDROME; PRIMS	0.00537634	0.5285087572275343
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.5285087572275343
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.5285087572275343
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.5285087572275343
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00537634	0.5285087572275343
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00537634	0.5285087572275343
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.5285087572275343
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00537634	0.5285087572275343
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.5285087572275343
EDINBURGH MALFORMATION SYNDROME	0.00537634	0.5285087572275343
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.5285087572275343
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00537634	0.5285087572275343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00537634	0.5285087572275343
ISOLATED TRIGONOCEPHALY	0.00537634	0.5285087572275343
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00537634	0.5285087572275343
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.5285087572275343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.00537634	0.5285087572275343
EMANUEL SYNDROME	0.0050898639999999995	0.5003473919240908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.0050898639999999995	0.5003473919240908
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.0050898639999999995	0.5003473919240908
MYOTONIA PERMANENS	0.0050796	0.49933841297480874
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0050796	0.49933841297480874
MOEBIUS SYNDROME; MBS	0.0050796	0.49933841297480874
RETT SYNDROME	0.00506677	0.4980771892882061
XERODERMA PIGMENTOSUM	0.00506677	0.4980771892882061
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.00506677	0.4980771892882061
MENKES DISEASE	0.00506677	0.4980771892882061
TRIPLE A SYNDROME	0.00506677	0.4980771892882061
NORRIE DISEASE	0.00506677	0.4980771892882061
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00506677	0.4980771892882061
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00506677	0.4980771892882061
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00506677	0.4980771892882061
TAY-SACHS DISEASE	0.004855894	0.47734750837347356
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004855894	0.47734750837347356
MYOCLONIC EPILEPSY OF INFANCY	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.004855894	0.47734750837347356
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.004855894	0.47734750837347356
ZTTK SYNDROME; ZTTKS	0.004855894	0.47734750837347356
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004855894	0.47734750837347356
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004855894	0.47734750837347356
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.004855894	0.47734750837347356
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.004855894	0.47734750837347356
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.47734750837347356
CHÉDIAK-HIGASHI SYNDROME	0.004855894	0.47734750837347356
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.004855894	0.47734750837347356
MUCOPOLYSACCHARIDOSIS TYPE 2	0.004855894	0.47734750837347356
SCHINDLER DISEASE, TYPE I	0.004855894	0.47734750837347356
CANAVAN DISEASE	0.004855894	0.47734750837347356
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.004855894	0.47734750837347356
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004855894	0.47734750837347356
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004855894	0.47734750837347356
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.47734750837347356
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.004855894	0.47734750837347356
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004855894	0.47734750837347356
MYOCLONIC-ASTASTIC EPILEPSY	0.004855894	0.47734750837347356
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.004855894	0.47734750837347356
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004855894	0.47734750837347356
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.004855894	0.47734750837347356
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.004855894	0.47734750837347356
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.004855894	0.47734750837347356
OPTIC PATHWAY GLIOMA	0.004855894	0.47734750837347356
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.004855894	0.47734750837347356
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.004855894	0.47734750837347356
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004855894	0.47734750837347356
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004750264	0.46696379379702474
RIDDLE SYNDROME	0.004750264	0.46696379379702474
3Q29 MICRODELETION SYNDROME	0.004750264	0.46696379379702474
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004750264	0.46696379379702474
16P13.2 MICRODELETION SYNDROME	0.004750264	0.46696379379702474
46,XX GONADAL DYSGENESIS	0.00454431	0.4467179587891868
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.4467179587891868
XYLOSIDASE DEFICIENCY	0.00454431	0.4467179587891868
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.4467179587891868
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00454431	0.4467179587891868
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00454431	0.4467179587891868
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004333434	0.42598827787445415
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.42598827787445415
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.42598827787445415
LARSEN-LIKE SYNDROME	0.004333434	0.42598827787445415
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004333434	0.42598827787445415
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.42598827787445415
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004333434	0.42598827787445415
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004333434	0.42598827787445415
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.42598827787445415
REVESZ SYNDROME	0.004333434	0.42598827787445415
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004333434	0.42598827787445415
SALLA DISEASE	0.004333434	0.42598827787445415
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00431034	0.42371807523856947
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00431034	0.42371807523856947
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.00431034	0.42371807523856947
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00431034	0.42371807523856947
RETT SYNDROME; RTT	0.00431034	0.42371807523856947
PANDAS	0.00431034	0.42371807523856947
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00431034	0.42371807523856947
CHILDHOOD DISINTEGRATIVE DISORDER	0.00431034	0.42371807523856947
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00431034	0.42371807523856947
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.42371807523856947
DYSOSTEOSCLEROSIS	0.00431034	0.42371807523856947
ADIPOSIS DOLOROSA	0.00431034	0.42371807523856947
CARNOSINASE DEFICIENCY	0.00431034	0.42371807523856947
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00431034	0.42371807523856947
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.42371807523856947
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00431034	0.42371807523856947
TRISOMY 5P	0.00431034	0.42371807523856947
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00431034	0.42371807523856947
WHIPPLE DISEASE	0.00431034	0.42371807523856947
CEREBROTENDINOUS XANTHOMATOSIS	0.00431034	0.42371807523856947
KRABBE DISEASE	0.00431034	0.42371807523856947
WOLFRAM SYNDROME	0.00431034	0.42371807523856947
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.42371807523856947
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00431034	0.42371807523856947
SNEDDON SYNDROME	0.00431034	0.42371807523856947
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00431034	0.42371807523856947
INFANTILE NEUROAXONAL DYSTROPHY	0.00431034	0.42371807523856947
ALEXANDER DISEASE	0.00431034	0.42371807523856947
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00431034	0.42371807523856947
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.42371807523856947
CANAVAN DISEASE	0.00431034	0.42371807523856947
GAUCHER DISEASE	0.00431034	0.42371807523856947
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00431034	0.42371807523856947
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.42371807523856947
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.42371807523856947
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00431034	0.42371807523856947
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00431034	0.42371807523856947
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.42371807523856947
WEST SYNDROME	0.00431034	0.42371807523856947
NASU-HAKOLA DISEASE	0.00431034	0.42371807523856947
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00431034	0.42371807523856947
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00431034	0.42371807523856947
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00431034	0.42371807523856947
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00431034	0.42371807523856947
RETT SYNDROME, CONGENITAL VARIANT	0.00431034	0.42371807523856947
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00431034	0.42371807523856947
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.42371807523856947
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00431034	0.42371807523856947
DYSOSTEOSCLEROSIS	0.00431034	0.42371807523856947
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.42371807523856947
MUCOLIPIDOSIS TYPE IV	0.00420471	0.41333436066212065
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00420471	0.41333436066212065
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00420471	0.41333436066212065
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00420471	0.41333436066212065
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00420471	0.41333436066212065
SCHWARTZ-JAMPEL SYNDROME	0.00420471	0.41333436066212065
COCKAYNE SYNDROME A; CSA	0.00420471	0.41333436066212065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00420471	0.41333436066212065
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00420471	0.41333436066212065
JOUBERT SYNDROME	0.003993834	0.392604679747388
JOUBERT SYNDROME WITH OCULAR DEFECT	0.003993834	0.392604679747388
KRABBE DISEASE	0.003993834	0.392604679747388
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.392604679747388
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.003993834	0.392604679747388
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.003993834	0.392604679747388
FRIED SYNDROME	0.003993834	0.392604679747388
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.392604679747388
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003993834	0.392604679747388
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.392604679747388
INCONTINENTIA PIGMENTI	0.003993834	0.392604679747388
FOIX-CHAVANY-MARIE SYNDROME	0.003993834	0.392604679747388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.003993834	0.392604679747388
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.003993834	0.392604679747388
JOUBERT SYNDROME 24	0.003993834	0.392604679747388
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.392604679747388
FREE SIALIC ACID STORAGE DISEASE	0.003993834	0.392604679747388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.392604679747388
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.003993834	0.392604679747388
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.003993834	0.392604679747388
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.392604679747388
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.003993834	0.392604679747388
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.003993834	0.392604679747388
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.392604679747388
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.003993834	0.392604679747388
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.392604679747388
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.003993834	0.392604679747388
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.392604679747388
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.003993834	0.392604679747388
JOUBERT SYNDROME WITH RENAL DEFECT	0.003993834	0.392604679747388
L1 SYNDROME	0.003993834	0.392604679747388
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.37235884473955005
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.37235884473955005
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.37235884473955005
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.37235884473955005
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.37235884473955005
PERRY SYNDROME	0.00378788	0.37235884473955005
SCHIZOPHRENIA 4	0.00378788	0.37235884473955005
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.37235884473955005
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.37235884473955005
OVARIAN CANCER	0.00378788	0.37235884473955005
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.37235884473955005
ETHANOLAMINOSIS	0.00378788	0.37235884473955005
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.37235884473955005
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.37235884473955005
PACMAN DYSPLASIA	0.00378788	0.37235884473955005
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.37235884473955005
PARAOXONASE 1	0.00378788	0.37235884473955005
GONADOBLASTOMA	0.00378788	0.37235884473955005
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.37235884473955005
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.37235884473955005
ONCOCYTOMA	0.00378788	0.37235884473955005
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.37235884473955005
MACROCYTOSIS, FAMILIAL	0.00378788	0.37235884473955005
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.37235884473955005
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.37235884473955005
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.37235884473955005
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.37235884473955005
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.37235884473955005
OSTEOMESOPYKNOSIS	0.00378788	0.37235884473955005
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.37235884473955005
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.37235884473955005
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.37235884473955005
DELETED IN AZOOSPERMIA	0.00378788	0.37235884473955005
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.37235884473955005
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.37235884473955005
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.37235884473955005
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.37235884473955005
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.37235884473955005
XM SYSTEM	0.00378788	0.37235884473955005
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.37235884473955005
MACULAR CORNEAL DYSTROPHY	0.00378788	0.37235884473955005
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.37235884473955005
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.37235884473955005
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.37235884473955005
CITRULLINE TRANSPORT DEFECT	0.00378788	0.37235884473955005
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.37235884473955005
PITUITARY DWARFISM IV	0.00378788	0.37235884473955005
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.37235884473955005
XANTHINURIA, TYPE I	0.00378788	0.37235884473955005
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.37235884473955005
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.37235884473955005
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.37235884473955005
GLOMUVENOUS MALFORMATIONS	0.00378788	0.37235884473955005
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.37235884473955005
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.37235884473955005
GLUTATHIONE REDUCTASE	0.00378788	0.37235884473955005
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.37235884473955005
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.37235884473955005
PENDRED SYNDROME	0.00378788	0.37235884473955005
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.37235884473955005
ACETYLATION, SLOW	0.00378788	0.37235884473955005
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.37235884473955005
ALKAPTONURIA	0.00378788	0.37235884473955005
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.37235884473955005
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.37235884473955005
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.37235884473955005
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.37235884473955005
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.37235884473955005
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.37235884473955005
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.37235884473955005
HEINZ BODY ANEMIAS	0.00378788	0.37235884473955005
HYPOASCORBEMIA	0.00378788	0.37235884473955005
HYPERPROGLUCAGONEMIA	0.00378788	0.37235884473955005
T-SUBSTANCE ANOMALY	0.00378788	0.37235884473955005
DERMATITIS, ATOPIC	0.00378788	0.37235884473955005
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.37235884473955005
FLOOD FACTOR DEFICIENCY	0.00378788	0.37235884473955005
APOLIPOPROTEIN(A)	0.00378788	0.37235884473955005
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.37235884473955005
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.37235884473955005
HOOFT DISEASE	0.00378788	0.37235884473955005
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.37235884473955005
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.37235884473955005
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.37235884473955005
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.37235884473955005
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.37235884473955005
TRISOMY 18-LIKE SYNDROME	0.00378788	0.37235884473955005
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.37235884473955005
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.37235884473955005
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.37235884473955005
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.37235884473955005
LYMPHOKINE DEFICIENCY	0.00378788	0.37235884473955005
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.37235884473955005
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.37235884473955005
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.37235884473955005
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.37235884473955005
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.37235884473955005
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.37235884473955005
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.37235884473955005
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.37235884473955005
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.37235884473955005
PROGESTERONE RESISTANCE	0.00378788	0.37235884473955005
LIPASE DEFICIENCY, COMBINED	0.00378788	0.37235884473955005
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.37235884473955005
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.37235884473955005
LARON SYNDROME	0.00378788	0.37235884473955005
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.37235884473955005
ZINC, ELEVATED PLASMA	0.00378788	0.37235884473955005
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.37235884473955005
COUMARIN RESISTANCE	0.00378788	0.37235884473955005
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.37235884473955005
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.37235884473955005
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.37235884473955005
GAPO SYNDROME; GAPOS	0.00378788	0.37235884473955005
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.37235884473955005
PYGMY	0.00378788	0.37235884473955005
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.37235884473955005
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.37235884473955005
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.37235884473955005
CALVARIAL HYPEROSTOSIS	0.00378788	0.37235884473955005
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.37235884473955005
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.37235884473955005
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.37235884473955005
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00378788	0.37235884473955005
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.37235884473955005
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.37235884473955005
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.37235884473955005
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.37235884473955005
FINGERPRINT BODY MYOPATHY	0.00378788	0.37235884473955005
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.37235884473955005
CEPHALIN LIPIDOSIS	0.00378788	0.37235884473955005
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.37235884473955005
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.37235884473955005
ALAND ISLAND EYE DISEASE	0.00378788	0.37235884473955005
ICHTHYOSIS, X-LINKED	0.00378788	0.37235884473955005
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.37235884473955005
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.37235884473955005
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.37235884473955005
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.37235884473955005
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.37235884473955005
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.37235884473955005
OSTEOGENIC SARCOMA	0.00378788	0.37235884473955005
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.37235884473955005
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.37235884473955005
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.37235884473955005
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.37235884473955005
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.37235884473955005
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.37235884473955005
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.37235884473955005
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.37235884473955005
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.37235884473955005
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.37235884473955005
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.37235884473955005
DERMATOLEUKODYSTROPHY	0.00378788	0.37235884473955005
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.37235884473955005
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.37235884473955005
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.37235884473955005
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.37235884473955005
AREDYLD	0.00378788	0.37235884473955005
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.37235884473955005
BEETURIA	0.00378788	0.37235884473955005
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.37235884473955005
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.37235884473955005
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.37235884473955005
CARBOXYLESTERASE 1	0.00378788	0.37235884473955005
GLUTATHIONURIA	0.00378788	0.37235884473955005
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.37235884473955005
BARTTER SYNDROME	0.00378788	0.37235884473955005
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.37235884473955005
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.37235884473955005
NEPHROSIALIDOSIS	0.00378788	0.37235884473955005
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.37235884473955005
PREMATURE OVARIAN FAILURE 1	0.00378788	0.37235884473955005
MYOPATHY, SPHEROID BODY	0.00378788	0.37235884473955005
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.37235884473955005
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.37235884473955005
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.37235884473955005
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.37235884473955005
SPINAL ARACHNOIDITIS	0.00378788	0.37235884473955005
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.37235884473955005
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.37235884473955005
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.37235884473955005
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.37235884473955005
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.37235884473955005
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.37235884473955005
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.37235884473955005
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.37235884473955005
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.37235884473955005
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.338975246612484
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.338975246612484
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.338975246612484
OSTEOGENESIS IMPERFECTA	0.00344828	0.338975246612484
X-LINKED CENTRONUCLEAR MYOPATHY	0.00344828	0.338975246612484
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.338975246612484
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.338975246612484
MUSCLE-EYE-BRAIN DISEASE	0.00344828	0.338975246612484
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.338975246612484
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.338975246612484
METACHROMATIC LEUKODYSTROPHY	0.00344828	0.338975246612484
CENTRONUCLEAR MYOPATHY	0.00344828	0.338975246612484
CLASSIC GALACTOSEMIA	0.00344828	0.338975246612484
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.338975246612484
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00344828	0.338975246612484
BEHR SYNDROME	0.00344828	0.338975246612484
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00344828	0.338975246612484
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.338975246612484
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.338975246612484
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.338975246612484
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00344828	0.338975246612484
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.338975246612484
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.338975246612484
MYOCLONIC EPILEPSY OF LAFORA	0.00344828	0.338975246612484
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.338975246612484
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.338975246612484
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.338975246612484
DYSTONIA 16; DYT16	0.00344828	0.338975246612484
SIALIDOSIS TYPE 1	0.00344828	0.338975246612484
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.338975246612484
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.338975246612484
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.338975246612484
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.338975246612484
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.338975246612484
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.00344828	0.338975246612484
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.338975246612484
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.338975246612484
CORTICOBASAL SYNDROME	0.00344828	0.338975246612484
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.338975246612484
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00344828	0.338975246612484
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.338975246612484
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.338975246612484
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00344828	0.338975246612484
BENIGN HEREDITARY CHOREA	0.00344828	0.338975246612484
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00344828	0.338975246612484
ROUSSY-LÉVY SYNDROME	0.00344828	0.338975246612484
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.338975246612484
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.338975246612484
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00344828	0.338975246612484
RHEUMATIC FEVER	0.00344828	0.338975246612484
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.338975246612484
MELNICK-NEEDLES SYNDROME	0.00344828	0.338975246612484
MYOTONIA FLUCTUANS	0.00344828	0.338975246612484
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.338975246612484
MANGANESE POISONING	0.00344828	0.338975246612484
HEREDITARY HYPEREKPLEXIA	0.00344828	0.338975246612484
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.338975246612484
ADULT POLYGLUCOSAN BODY DISEASE	0.00344828	0.338975246612484
MAST SYNDROME	0.00344828	0.338975246612484
PSEUDOACHONDROPLASIA	0.00344828	0.338975246612484
THORACOMELIC DYSPLASIA	0.00344828	0.338975246612484
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.338975246612484
KUSKOKWIM SYNDROME	0.00344828	0.338975246612484
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.338975246612484
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.338975246612484
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.338975246612484
LERI PLEONOSTEOSIS	0.00344828	0.338975246612484
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00344828	0.338975246612484
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.338975246612484
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.338975246612484
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.338975246612484
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.338975246612484
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.338975246612484
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.338975246612484
POLYMYOSITIS	0.00344828	0.338975246612484
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.338975246612484
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.338975246612484
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.338975246612484
ATAXIA-TELANGIECTASIA	0.00344828	0.338975246612484
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.338975246612484
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00344828	0.338975246612484
RICHARDS-RUNDLE SYNDROME	0.00344828	0.338975246612484
CYSTINOSIS	0.00344828	0.338975246612484
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.338975246612484
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.338975246612484
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.338975246612484
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.338975246612484
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.338975246612484
FAMILIAL DYSAUTONOMIA	0.00344828	0.338975246612484
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.338975246612484
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.338975246612484
DYSEQUILIBRIUM SYNDROME	0.00344828	0.338975246612484
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00344828	0.338975246612484
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.338975246612484
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.338975246612484
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.338975246612484
GAUCHER DISEASE TYPE 3	0.00344828	0.338975246612484
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.338975246612484
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.338975246612484
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.338975246612484
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.338975246612484
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.338975246612484
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.338975246612484
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.338975246612484
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.338975246612484
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.338975246612484
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.338975246612484
KUFOR-RAKEB SYNDROME	0.00344828	0.338975246612484
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.338975246612484
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.338975246612484
ALZHEIMER DISEASE 3; AD	0.00344828	0.338975246612484
NONAKA MYOPATHY	0.00344828	0.338975246612484
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.338975246612484
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.338975246612484
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00344828	0.338975246612484
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.338975246612484
SPONASTRIME DYSPLASIA	0.00344828	0.338975246612484
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.338975246612484
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.338975246612484
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.338975246612484
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.338975246612484
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.338975246612484
KALLMANN SYNDROME	0.00344828	0.338975246612484
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00344828	0.338975246612484
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.338975246612484
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.338975246612484
TENORIO SYNDROME; TNORS	0.00344828	0.338975246612484
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.338975246612484
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00344828	0.338975246612484
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.338975246612484
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.338975246612484
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.338975246612484
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.338975246612484
BRITTLE CORNEA SYNDROME	0.00344828	0.338975246612484
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.338975246612484
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.338975246612484
NEMALINE MYOPATHY 6	0.00344828	0.338975246612484
KENNEDY DISEASE	0.00344828	0.338975246612484
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.338975246612484
MASA SYNDROME	0.00344828	0.338975246612484
DYSTONIA 23; DYT23	0.00344828	0.338975246612484
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.338975246612484
PARTINGTON SYNDROME	0.00344828	0.338975246612484
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.338975246612484
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00344828	0.338975246612484
OSTEOCHONDRITIS DISSECANS	0.00344828	0.338975246612484
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.338975246612484
SUBEPENDYMOMA	0.00344828	0.338975246612484
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.338975246612484
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00344828	0.338975246612484
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.338975246612484
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.338975246612484
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.338975246612484
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.338975246612484
EPENDYMOMA	0.00344828	0.338975246612484
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.338975246612484
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.338975246612484
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.338975246612484
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0029333039999999994	0.2883517135468655
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0029333039999999994	0.2883517135468655
LATHOSTEROLOSIS	0.0029333039999999994	0.2883517135468655
RING CHROMOSOME 14 SYNDROME	0.0029333039999999994	0.2883517135468655
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0029333039999999994	0.2883517135468655
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0029333039999999994	0.2883517135468655
HOLMES-GANG SYNDROME	0.0029333039999999994	0.2883517135468655
CEREBROFACIOARTICULAR SYNDROME	0.0029333039999999994	0.2883517135468655
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0029333039999999994	0.2883517135468655
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0029333039999999994	0.2883517135468655
ROTHMUND-THOMSON SYNDROME	0.0029333039999999994	0.2883517135468655
DISTAL MONOSOMY 1Q	0.0029333039999999994	0.2883517135468655
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0029333039999999994	0.2883517135468655
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.2883517135468655
MONOSOMY 13Q34	0.0029333039999999994	0.2883517135468655
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0029333039999999994	0.2883517135468655
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0029333039999999994	0.2883517135468655
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.0029333039999999994	0.2883517135468655
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0029333039999999994	0.2883517135468655
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0029333039999999994	0.2883517135468655
15Q24 MICRODELETION SYNDROME	0.0029333039999999994	0.2883517135468655
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0029333039999999994	0.2883517135468655
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0029333039999999994	0.2883517135468655
C SYNDROME	0.0029333039999999994	0.2883517135468655
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0029333039999999994	0.2883517135468655
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0029333039999999994	0.2883517135468655
COFFIN-SIRIS SYNDROME	0.0029333039999999994	0.2883517135468655
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0029333039999999994	0.2883517135468655
6Q16 MICRODELETION SYNDROME	0.0029333039999999994	0.2883517135468655
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.0029333039999999994	0.2883517135468655
CHARGE SYNDROME	0.0029333039999999994	0.2883517135468655
CK SYNDROME	0.0029333039999999994	0.2883517135468655
DISTAL MONOSOMY 10Q	0.0029333039999999994	0.2883517135468655
LIG4 SYNDROME	0.0029333039999999994	0.2883517135468655
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0029333039999999994	0.2883517135468655
HARTSFIELD SYNDROME; HRTFDS	0.0029333039999999994	0.2883517135468655
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0029333039999999994	0.2883517135468655
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0029333039999999994	0.2883517135468655
RUBINSTEIN-TAYBI SYNDROME	0.0029333039999999994	0.2883517135468655
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0029333039999999994	0.2883517135468655
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0029333039999999994	0.2883517135468655
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0029333039999999994	0.2883517135468655
TRICHOTHIODYSTROPHY	0.0029333039999999994	0.2883517135468655
TOLUENE EMBRYOPATHY	0.0029333039999999994	0.2883517135468655
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0029333039999999994	0.2883517135468655
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0029333039999999994	0.2883517135468655
PHENOBARBITAL EMBRYOPATHY	0.0029333039999999994	0.2883517135468655
WARSAW BREAKAGE SYNDROME; WABS	0.0029333039999999994	0.2883517135468655
DISTAL TRISOMY 17Q	0.0029333039999999994	0.2883517135468655
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0029333039999999994	0.2883517135468655
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0029333039999999994	0.2883517135468655
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0029333039999999994	0.2883517135468655
FETAL ALCOHOL SYNDROME	0.0029333039999999994	0.2883517135468655
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0029333039999999994	0.2883517135468655
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0029333039999999994	0.2883517135468655
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0029333039999999994	0.2883517135468655
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0029333039999999994	0.2883517135468655
HADZISELIMOVIC SYNDROME	0.0029333039999999994	0.2883517135468655
OGDEN SYNDROME; OGDNS	0.0029333039999999994	0.2883517135468655
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0029333039999999994	0.2883517135468655
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0029333039999999994	0.2883517135468655
SMITH-LEMLI-OPITZ SYNDROME	0.0029333039999999994	0.2883517135468655
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0029333039999999994	0.2883517135468655
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0029333039999999994	0.2883517135468655
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0029333039999999994	0.2883517135468655
22Q11.2 DELETION SYNDROME	0.0029333039999999994	0.2883517135468655
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0029333039999999994	0.2883517135468655
FANCONI ANEMIA	0.0029333039999999994	0.2883517135468655
1Q21.1 MICRODELETION SYNDROME	0.0029333039999999994	0.2883517135468655
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0029333039999999994	0.2883517135468655
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0029333039999999994	0.2883517135468655
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0029333039999999994	0.2883517135468655
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0029333039999999994	0.2883517135468655
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0029333039999999994	0.2883517135468655
8P11.2 DELETION SYNDROME	0.0029333039999999994	0.2883517135468655
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0029333039999999994	0.2883517135468655
MATERNAL PHENYLKETONURIA	0.0029333039999999994	0.2883517135468655
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0029333039999999994	0.2883517135468655
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0029333039999999994	0.2883517135468655
PEHO SYNDROME	0.0029333039999999994	0.2883517135468655
MONOSOMY 18P	0.0029333039999999994	0.2883517135468655
MONOSOMY 18Q	0.0029333039999999994	0.2883517135468655
6Q25 MICRODELETION SYNDROME	0.0029333039999999994	0.2883517135468655
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0029333039999999994	0.2883517135468655
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0029333039999999994	0.2883517135468655
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0029333039999999994	0.2883517135468655
20Q11.2 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.2883517135468655
KOOLEN-DE VRIES SYNDROME	0.0029333039999999994	0.2883517135468655
15Q13.3 MICRODELETION SYNDROME	0.0029333039999999994	0.2883517135468655
8P23.1 MICRODELETION SYNDROME	0.0029333039999999994	0.2883517135468655
19P13.3 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.2883517135468655
22Q11.2 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.2883517135468655
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00238775	0.2347222804119615
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00238775	0.2347222804119615
COFFIN-SIRIS SYNDROME 10; CSS10	0.00238775	0.2347222804119615
MARTSOLF SYNDROME	0.00238775	0.2347222804119615
CRI-DU-CHAT SYNDROME	0.00238775	0.2347222804119615
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00238775	0.2347222804119615
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00238775	0.2347222804119615
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00238775	0.2347222804119615
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00238775	0.2347222804119615
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00238775	0.2347222804119615
LATHOSTEROLOSIS	0.00238775	0.2347222804119615
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00238775	0.2347222804119615
C SYNDROME	0.00238775	0.2347222804119615
MARDEN-WALKER SYNDROME	0.00238775	0.2347222804119615
DUBOWITZ SYNDROME	0.00238775	0.2347222804119615
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00238775	0.2347222804119615
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00238775	0.2347222804119615
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00238775	0.2347222804119615
CAREY-FINEMAN-ZITER SYNDROME	0.00238775	0.2347222804119615
DESMOSTEROLOSIS	0.00238775	0.2347222804119615
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00238775	0.2347222804119615
OROFACIODIGITAL SYNDROME I; OFD1	0.00238775	0.2347222804119615
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00238775	0.2347222804119615
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00238775	0.2347222804119615
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00238775	0.2347222804119615
RING CHROMOSOME 13 SYNDROME	0.00238775	0.2347222804119615
FEINGOLD SYNDROME 1; FGLDS1	0.00238775	0.2347222804119615
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00238775	0.2347222804119615
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00238775	0.2347222804119615
RENPENNING SYNDROME 1; RENS1	0.00238775	0.2347222804119615
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00238775	0.2347222804119615
ACHALASIA-MICROCEPHALY SYNDROME	0.00238775	0.2347222804119615
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00238775	0.2347222804119615
DUBOWITZ SYNDROME	0.00238775	0.2347222804119615
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00238775	0.2347222804119615
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00238775	0.2347222804119615
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00238775	0.2347222804119615
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00238775	0.2347222804119615
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00238775	0.2347222804119615
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00238775	0.2347222804119615
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00238775	0.2347222804119615
CHROMOSOME 18Q DELETION SYNDROME	0.00238775	0.2347222804119615
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00238775	0.2347222804119615
JACOBSEN SYNDROME	0.00238775	0.2347222804119615
RENPENNING SYNDROME	0.00238775	0.2347222804119615
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00238775	0.2347222804119615
DISTAL MONOSOMY 3P	0.00238775	0.2347222804119615
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00238775	0.2347222804119615
MOWAT-WILSON SYNDROME	0.00238775	0.2347222804119615
MONOSOMY 13Q14	0.00238775	0.2347222804119615
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00238775	0.2347222804119615
ACROOTOOCULAR SYNDROME	0.00238775	0.2347222804119615
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00238775	0.2347222804119615
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00238775	0.2347222804119615
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00238775	0.2347222804119615
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00238775	0.2347222804119615
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00238775	0.2347222804119615
PRIMARY PULMONARY HYPOPLASIA	0.00238775	0.2347222804119615
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00238775	0.2347222804119615
RING CHROMOSOME 6 SYNDROME	0.00238775	0.2347222804119615
DISTAL TRISOMY 5Q	0.00238775	0.2347222804119615
DIAMOND-BLACKFAN ANEMIA 1	0.00238775	0.2347222804119615
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00238775	0.2347222804119615
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00238775	0.2347222804119615
GMS SYNDROME	0.00238775	0.2347222804119615
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0021768739999999996	0.21399259949722885
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.21399259949722885
PSEUDOAMINOPTERIN SYNDROME	0.0021768739999999996	0.21399259949722885
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722885
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0021768739999999996	0.21399259949722885
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.21399259949722885
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0021768739999999996	0.21399259949722885
CHROMOSOME 16Q22 DELETION SYNDROME	0.0021768739999999996	0.21399259949722885
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.21399259949722885
JACOBSEN SYNDROME	0.0021768739999999996	0.21399259949722885
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0021768739999999996	0.21399259949722885
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.21399259949722885
16P11.2P12.2 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722885
20P12.3 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722885
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.21399259949722885
ICF SYNDROME	0.0021768739999999996	0.21399259949722885
48,XYYY SYNDROME	0.0021768739999999996	0.21399259949722885
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0021768739999999996	0.21399259949722885
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.21399259949722885
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0021768739999999996	0.21399259949722885
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0021768739999999996	0.21399259949722885
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.0021768739999999996	0.21399259949722885
PMM2-CDG	0.0021768739999999996	0.21399259949722885
PEHO SYNDROME; PEHO	0.0021768739999999996	0.21399259949722885
TETRASOMY X	0.0021768739999999996	0.21399259949722885
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0021768739999999996	0.21399259949722885
X SMALL RINGS	0.0021768739999999996	0.21399259949722885
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.21399259949722885
WEAVER SYNDROME	0.0021768739999999996	0.21399259949722885
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0021768739999999996	0.21399259949722885
TRISOMY X	0.0021768739999999996	0.21399259949722885
SIMPSON-GOLABI-BEHMEL SYNDROME	0.0021768739999999996	0.21399259949722885
TRISOMY 12P	0.0021768739999999996	0.21399259949722885
INFANTILE SIALIC ACID STORAGE DISEASE	0.0021768739999999996	0.21399259949722885
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0021768739999999996	0.21399259949722885
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0021768739999999996	0.21399259949722885
8Q12 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722885
DISTAL MONOSOMY 9P	0.0021768739999999996	0.21399259949722885
14Q22Q23 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722885
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.21399259949722885
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.21399259949722885
8Q24.3 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722885
48,XXYY SYNDROME	0.0021768739999999996	0.21399259949722885
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.21399259949722885
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.21399259949722885
COSTELLO SYNDROME; CSTLO	0.0021768739999999996	0.21399259949722885
TETRASOMY 9P	0.0021768739999999996	0.21399259949722885
DISTAL MONOSOMY 6P	0.0021768739999999996	0.21399259949722885
DE BARSY SYNDROME	0.0021768739999999996	0.21399259949722885
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0021768739999999996	0.21399259949722885
TETRASOMY 5P	0.0021768739999999996	0.21399259949722885
OROFACIODIGITAL SYNDROME VI	0.0021768739999999996	0.21399259949722885
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.21399259949722885
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.21399259949722885
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0021768739999999996	0.21399259949722885
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0021768739999999996	0.21399259949722885
19P13.13 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722885
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.21399259949722885
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0021768739999999996	0.21399259949722885
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0021768739999999996	0.21399259949722885
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0021768739999999996	0.21399259949722885
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.21399259949722885
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.21399259949722885
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0021768739999999996	0.21399259949722885
WRINKLY SKIN SYNDROME	0.0021768739999999996	0.21399259949722885
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.21399259949722885
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722885
PEHO-LIKE SYNDROME; PEHOL	0.0021768739999999996	0.21399259949722885
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.21399259949722885
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.21399259949722885
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021768739999999996	0.21399259949722885
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.21399259949722885
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.21399259949722885
15Q11Q13 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722885
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0021768739999999996	0.21399259949722885
JOUBERT SYNDROME 14	0.0021768739999999996	0.21399259949722885
PERLMAN SYNDROME	0.0021768739999999996	0.21399259949722885
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021768739999999996	0.21399259949722885
POTOCKI-SHAFFER SYNDROME	0.0021768739999999996	0.21399259949722885
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0021768739999999996	0.21399259949722885
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0021768739999999996	0.21399259949722885
SIALURIA	0.0021768739999999996	0.21399259949722885
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.21399259949722885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0021768739999999996	0.21399259949722885
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0021768739999999996	0.21399259949722885
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.21399259949722885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0021768739999999996	0.21399259949722885
JOUBERT SYNDROME 10	0.0021768739999999996	0.21399259949722885
CODAS SYNDROME	0.0021768739999999996	0.21399259949722885
CARDIOFACIOCUTANEOUS SYNDROME	0.0021768739999999996	0.21399259949722885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.21399259949722885
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.21399259949722885
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.21399259949722885
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0021768739999999996	0.21399259949722885
MONOSOMY 9Q22.3	0.0021768739999999996	0.21399259949722885
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0021768739999999996	0.21399259949722885
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.21399259949722885
48,XXXY SYNDROME	0.0021768739999999996	0.21399259949722885
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.21399259949722885
COFFIN-SIRIS SYNDROME 6; CSS6	0.0021768739999999996	0.21399259949722885
49,XXXXY SYNDROME	0.0021768739999999996	0.21399259949722885
XQ25 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722885
MONOSOMY 22Q13.3	0.0021768739999999996	0.21399259949722885
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.21399259949722885
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.21399259949722885
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.21399259949722885
XQ25 DUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722885
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.0021768739999999996	0.21399259949722885
JOUBERT SYNDROME 1	0.0021768739999999996	0.21399259949722885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.21399259949722885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0021768739999999996	0.21399259949722885
BAKER-GORDON SYNDROME; BAGOS	0.0021768739999999996	0.21399259949722885
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.21399259949722885
CHROMOSOME 9P DELETION SYNDROME	0.0021768739999999996	0.21399259949722885
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0021768739999999996	0.21399259949722885
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.21399259949722885
LAMB-SHAFFER SYNDROME	0.0021768739999999996	0.21399259949722885
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.16036316636232478
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.16036316636232478
CARTILAGE-HAIR HYPOPLASIA	0.00163132	0.16036316636232478
ACRODYSOSTOSIS	0.00163132	0.16036316636232478
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00163132	0.16036316636232478
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.16036316636232478
RING CHROMOSOME 8 SYNDROME	0.00163132	0.16036316636232478
NOONAN SYNDROME 8; NS8	0.00163132	0.16036316636232478
OROFACIODIGITAL SYNDROME TYPE 1	0.00163132	0.16036316636232478
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.16036316636232478
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.16036316636232478
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.16036316636232478
RENAL AGENESIS, BILATERAL	0.00163132	0.16036316636232478
MOMO SYNDROME	0.00163132	0.16036316636232478
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.16036316636232478
MOEBIUS SYNDROME	0.00163132	0.16036316636232478
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.16036316636232478
JUBERG-MARSIDI SYNDROME	0.00163132	0.16036316636232478
ATELOSTEOGENESIS TYPE II	0.00163132	0.16036316636232478
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.16036316636232478
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00163132	0.16036316636232478
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.16036316636232478
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.16036316636232478
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00163132	0.16036316636232478
SCHOLTE SYNDROME; SHLTS	0.00163132	0.16036316636232478
KNOBLOCH SYNDROME	0.00163132	0.16036316636232478
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.16036316636232478
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00163132	0.16036316636232478
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.16036316636232478
BALLER-GEROLD SYNDROME	0.00163132	0.16036316636232478
OMODYSPLASIA 1; OMOD1	0.00163132	0.16036316636232478
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.16036316636232478
6P22 MICRODELETION SYNDROME	0.00163132	0.16036316636232478
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.16036316636232478
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00163132	0.16036316636232478
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.16036316636232478
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.00163132	0.16036316636232478
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.16036316636232478
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.16036316636232478
BRITTLE CORNEA SYNDROME	0.00163132	0.16036316636232478
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.16036316636232478
JOUBERT SYNDROME 3; JBTS3	0.00163132	0.16036316636232478
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.16036316636232478
3Q13 MICRODELETION SYNDROME	0.00163132	0.16036316636232478
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.16036316636232478
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.16036316636232478
NEUROFACIODIGITORENAL SYNDROME	0.00163132	0.16036316636232478
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.16036316636232478
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.16036316636232478
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00163132	0.16036316636232478
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.16036316636232478
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.16036316636232478
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.16036316636232478
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00163132	0.16036316636232478
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.16036316636232478
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.16036316636232478
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.16036316636232478
HENNEKAM SYNDROME	0.00163132	0.16036316636232478
ZUNICH NEUROECTODERMAL SYNDROME	0.00163132	0.16036316636232478
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00163132	0.16036316636232478
3P25.3 MICRODELETION SYNDROME	0.00163132	0.16036316636232478
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.16036316636232478
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.16036316636232478
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.16036316636232478
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00163132	0.16036316636232478
CRANIOECTODERMAL DYSPLASIA 1	0.00163132	0.16036316636232478
POTOCKI-SHAFFER SYNDROME	0.00163132	0.16036316636232478
BRADDOCK SYNDROME	0.00163132	0.16036316636232478
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.16036316636232478
OROFACIAL CLEFT 15	0.00163132	0.16036316636232478
SUMMITT SYNDROME	0.00163132	0.16036316636232478
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00163132	0.16036316636232478
16P12.1P12.3 TRIPLICATION SYNDROME	0.00163132	0.16036316636232478
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.16036316636232478
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.16036316636232478
FRONTORHINY	0.00163132	0.16036316636232478
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.16036316636232478
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232478
LAURENCE-MOON SYNDROME	0.00163132	0.16036316636232478
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232478
CHIME SYNDROME	0.00163132	0.16036316636232478
KEIPERT SYNDROME	0.00163132	0.16036316636232478
ACROCALLOSAL SYNDROME; ACLS	0.00163132	0.16036316636232478
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.16036316636232478
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.16036316636232478
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00163132	0.16036316636232478
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.16036316636232478
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.16036316636232478
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.16036316636232478
STICKLER SYNDROME	0.00163132	0.16036316636232478
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.16036316636232478
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.16036316636232478
NOONAN SYNDROME 4; NS4	0.00163132	0.16036316636232478
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00163132	0.16036316636232478
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.16036316636232478
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.16036316636232478
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.16036316636232478
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.16036316636232478
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.16036316636232478
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.16036316636232478
PALLISTER-KILLIAN SYNDROME	0.00163132	0.16036316636232478
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.16036316636232478
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.16036316636232478
PENOSCROTAL TRANSPOSITION	0.00163132	0.16036316636232478
MILROY DISEASE	0.00163132	0.16036316636232478
VELO-FACIAL-SKELETAL SYNDROME	0.00163132	0.16036316636232478
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.16036316636232478
ACROCEPHALOPOLYDACTYLY	0.00163132	0.16036316636232478
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00163132	0.16036316636232478
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.16036316636232478
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.16036316636232478
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00163132	0.16036316636232478
20Q13.33 MICRODELETION SYNDROME	0.00163132	0.16036316636232478
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00163132	0.16036316636232478
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.16036316636232478
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00163132	0.16036316636232478
MECKEL SYNDROME, TYPE 10; MKS10	0.00163132	0.16036316636232478
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.16036316636232478
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.16036316636232478
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00163132	0.16036316636232478
MOSAIC MONOSOMY X	0.00163132	0.16036316636232478
PHAVER SYNDROME	0.00163132	0.16036316636232478
TURNER SYNDROME	0.00163132	0.16036316636232478
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00163132	0.16036316636232478
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.16036316636232478
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.16036316636232478
SHPRINTZEN OMPHALOCELE SYNDROME	0.00163132	0.16036316636232478
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.16036316636232478
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.16036316636232478
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.16036316636232478
GORLIN SYNDROME	0.00163132	0.16036316636232478
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.16036316636232478
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.16036316636232478
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.16036316636232478
LEGIUS SYNDROME	0.00163132	0.16036316636232478
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.16036316636232478
MEGAEPIPHYSEAL DWARFISM	0.00163132	0.16036316636232478
MONOSOMY X	0.00163132	0.16036316636232478
PTERYGIUM COLLI, ISOLATED	0.00163132	0.16036316636232478
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.16036316636232478
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.16036316636232478
CHROMOSOME 17Q12 DELETION SYNDROME	0.00163132	0.16036316636232478
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.16036316636232478
OHDO SYNDROME	0.00163132	0.16036316636232478
SILLENCE SYNDROME	0.00163132	0.16036316636232478
SCARF SYNDROME	0.00163132	0.16036316636232478
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00163132	0.16036316636232478
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.16036316636232478
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.16036316636232478
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.16036316636232478
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.16036316636232478
EPICANTHUS	0.00163132	0.16036316636232478
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.16036316636232478
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.16036316636232478
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.16036316636232478
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.16036316636232478
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.16036316636232478
FETAL VALPROATE SYNDROME	0.00163132	0.16036316636232478
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.16036316636232478
FRAXE INTELLECTUAL DISABILITY	0.00163132	0.16036316636232478
CLASSICAL EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232478
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232478
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.12798854718454078
3Q29 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454078
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001301984	0.12798854718454078
MARINESCO-SJÖGREN SYNDROME	0.001301984	0.12798854718454078
16P13.11 MICRODELETION SYNDROME	0.001301984	0.12798854718454078
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454078
MICRO SYNDROME	0.001301984	0.12798854718454078
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454078
15Q14 MICRODELETION SYNDROME	0.001301984	0.12798854718454078
HYPERTRICHOSIS CUBITI	0.001301984	0.12798854718454078
TRISOMY 17P	0.001301984	0.12798854718454078
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.12798854718454078
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.12798854718454078
MEVALONIC ACIDURIA	0.001301984	0.12798854718454078
COHEN SYNDROME	0.001301984	0.12798854718454078
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.12798854718454078
LISSENCEPHALY 2; LIS2	0.001301984	0.12798854718454078
OCULO-PALATO-CEREBRAL SYNDROME	0.001301984	0.12798854718454078
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.12798854718454078
OROFACIODIGITAL SYNDROME TYPE 4	0.001301984	0.12798854718454078
PITT-HOPKINS SYNDROME	0.001301984	0.12798854718454078
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001301984	0.12798854718454078
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001301984	0.12798854718454078
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.12798854718454078
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001301984	0.12798854718454078
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.12798854718454078
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001301984	0.12798854718454078
COG4-CDG	0.001301984	0.12798854718454078
RAINE SYNDROME	0.001301984	0.12798854718454078
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001301984	0.12798854718454078
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.12798854718454078
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.12798854718454078
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001301984	0.12798854718454078
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.12798854718454078
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001301984	0.12798854718454078
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001301984	0.12798854718454078
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.12798854718454078
OROFACIODIGITAL SYNDROME IX; OFD9	0.001301984	0.12798854718454078
MEHMO SYNDROME; MEHMO	0.001301984	0.12798854718454078
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001301984	0.12798854718454078
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.12798854718454078
MIETENS SYNDROME	0.001301984	0.12798854718454078
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001301984	0.12798854718454078
GALLOWAY-MOWAT SYNDROME	0.001301984	0.12798854718454078
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.12798854718454078
PEDIATRIC-ONSET GRAVES DISEASE	0.001301984	0.12798854718454078
TRISOMY 9P	0.001301984	0.12798854718454078
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001301984	0.12798854718454078
EAR-PATELLA-SHORT STATURE SYNDROME	0.001301984	0.12798854718454078
CONGENITAL VARICELLA SYNDROME	0.001301984	0.12798854718454078
PETERS-PLUS SYNDROME; PTRPLS	0.001301984	0.12798854718454078
17P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454078
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.12798854718454078
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454078
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001301984	0.12798854718454078
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.12798854718454078
MARDEN-WALKER SYNDROME	0.001301984	0.12798854718454078
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.001301984	0.12798854718454078
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.12798854718454078
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001301984	0.12798854718454078
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.12798854718454078
OKAMOTO SYNDROME	0.001301984	0.12798854718454078
ALG11-CDG	0.001301984	0.12798854718454078
DUANE RETRACTION SYNDROME	0.001301984	0.12798854718454078
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001301984	0.12798854718454078
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001301984	0.12798854718454078
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001301984	0.12798854718454078
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001301984	0.12798854718454078
CONGENITAL TOXOPLASMOSIS	0.001301984	0.12798854718454078
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001301984	0.12798854718454078
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.12798854718454078
HOLOPROSENCEPHALY 1; HPE1	0.001301984	0.12798854718454078
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001301984	0.12798854718454078
GALACTOSEMIA	0.001301984	0.12798854718454078
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001301984	0.12798854718454078
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001301984	0.12798854718454078
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001301984	0.12798854718454078
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001301984	0.12798854718454078
WHITE-SUTTON SYNDROME; WHSUS	0.001301984	0.12798854718454078
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001301984	0.12798854718454078
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001301984	0.12798854718454078
LIG4 SYNDROME	0.001301984	0.12798854718454078
AL-RAQAD SYNDROME; ARS	0.001301984	0.12798854718454078
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001301984	0.12798854718454078
WALKER-WARBURG SYNDROME	0.001301984	0.12798854718454078
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001301984	0.12798854718454078
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001301984	0.12798854718454078
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001301984	0.12798854718454078
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001301984	0.12798854718454078
SECKEL SYNDROME 8; SCKL8	0.001301984	0.12798854718454078
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001301984	0.12798854718454078
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001301984	0.12798854718454078
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.12798854718454078
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001301984	0.12798854718454078
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.12798854718454078
SLC35A2-CDG	0.001301984	0.12798854718454078
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001301984	0.12798854718454078
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001301984	0.12798854718454078
DPAGT1-CDG	0.001301984	0.12798854718454078
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.12798854718454078
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.12798854718454078
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001301984	0.12798854718454078
COFFIN-SIRIS SYNDROME 5	0.001301984	0.12798854718454078
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.12798854718454078
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001301984	0.12798854718454078
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001301984	0.12798854718454078
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.12798854718454078
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001301984	0.12798854718454078
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001301984	0.12798854718454078
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001301984	0.12798854718454078
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001301984	0.12798854718454078
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.12798854718454078
LISSENCEPHALY 8; LIS8	0.001301984	0.12798854718454078
HEART AND BRAIN MALFORMATION SYNDROME	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001301984	0.12798854718454078
GENITOPATELLAR SYNDROME	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.001301984	0.12798854718454078
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001301984	0.12798854718454078
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.12798854718454078
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.12798854718454078
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001301984	0.12798854718454078
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.12798854718454078
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.12798854718454078
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.12798854718454078
ROIFMAN SYNDROME; RFMN	0.001301984	0.12798854718454078
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.12798854718454078
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454078
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001301984	0.12798854718454078
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001301984	0.12798854718454078
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.12798854718454078
SECKEL SYNDROME 9; SCKL9	0.001301984	0.12798854718454078
BRESEK SYNDROME	0.001301984	0.12798854718454078
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001301984	0.12798854718454078
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.12798854718454078
LISSENCEPHALY 4	0.001301984	0.12798854718454078
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001301984	0.12798854718454078
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.12798854718454078
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001301984	0.12798854718454078
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.12798854718454078
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001301984	0.12798854718454078
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001301984	0.12798854718454078
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454078
ADAMS-OLIVER SYNDROME 1; AOS1	0.001301984	0.12798854718454078
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001301984	0.12798854718454078
ADAMS-OLIVER SYNDROME 2; AOS2	0.001301984	0.12798854718454078
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001301984	0.12798854718454078
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001301984	0.12798854718454078
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.12798854718454078
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.001301984	0.12798854718454078
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.12798854718454078
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.12798854718454078
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001301984	0.12798854718454078
PHACE SYNDROME	0.001301984	0.12798854718454078
GLASS SYNDROME	0.001301984	0.12798854718454078
MOSAIC TRISOMY 9	0.001301984	0.12798854718454078
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001301984	0.12798854718454078
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.12798854718454078
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.12798854718454078
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001301984	0.12798854718454078
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.12798854718454078
BETA-UREIDOPROPIONASE DEFICIENCY	0.001301984	0.12798854718454078
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.12798854718454078
XQ28 (MECP2) DUPLICATION	0.001301984	0.12798854718454078
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.12798854718454078
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.12798854718454078
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.12798854718454078
MEVALONIC ACIDURIA; MEVA	0.001301984	0.12798854718454078
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.12798854718454078
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.12798854718454078
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001301984	0.12798854718454078
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001301984	0.12798854718454078
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001301984	0.12798854718454078
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001301984	0.12798854718454078
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.001301984	0.12798854718454078
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.12798854718454078
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001301984	0.12798854718454078
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001301984	0.12798854718454078
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001301984	0.12798854718454078
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001301984	0.12798854718454078
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.12798854718454078
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001301984	0.12798854718454078
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001301984	0.12798854718454078
TOWNES-BROCKS SYNDROME 1; TBS1	0.001301984	0.12798854718454078
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001301984	0.12798854718454078
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001301984	0.12798854718454078
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001301984	0.12798854718454078
EMANUEL SYNDROME	0.001301984	0.12798854718454078
COFFIN-SIRIS SYNDROME 3; CSS3	0.001301984	0.12798854718454078
COFFIN-SIRIS SYNDROME 4; CSS4	0.001301984	0.12798854718454078
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001301984	0.12798854718454078
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001301984	0.12798854718454078
DISTAL MONOSOMY 12Q	0.001301984	0.12798854718454078
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.12798854718454078
ALAZAMI SYNDROME; ALAZS	0.001301984	0.12798854718454078
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.12798854718454078
SSR4-CDG	0.001301984	0.12798854718454078
STT3B-CDG	0.001301984	0.12798854718454078
STT3A-CDG	0.001301984	0.12798854718454078
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454078
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.12798854718454078
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001301984	0.12798854718454078
MYHRE SYNDROME	0.001301984	0.12798854718454078
KABUKI SYNDROME 1	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001301984	0.12798854718454078
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.12798854718454078
PETERS PLUS SYNDROME	0.001301984	0.12798854718454078
LOWRY-MACLEAN SYNDROME	0.001301984	0.12798854718454078
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001301984	0.12798854718454078
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.12798854718454078
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001301984	0.12798854718454078
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.12798854718454078
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.12798854718454078
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.12798854718454078
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.001301984	0.12798854718454078
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001301984	0.12798854718454078
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.12798854718454078
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001301984	0.12798854718454078
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.12798854718454078
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.001301984	0.12798854718454078
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001301984	0.12798854718454078
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.12798854718454078
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001301984	0.12798854718454078
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001301984	0.12798854718454078
JABERI-ELAHI SYNDROME; JABELS	0.001301984	0.12798854718454078
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.12798854718454078
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001301984	0.12798854718454078
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001301984	0.12798854718454078
CHROMOSOME 1P35 DELETION SYNDROME	0.001301984	0.12798854718454078
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001301984	0.12798854718454078
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001301984	0.12798854718454078
KBG SYNDROME	0.001301984	0.12798854718454078
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001301984	0.12798854718454078
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001301984	0.12798854718454078
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.12798854718454078
PENTASOMY X	0.001301984	0.12798854718454078
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001301984	0.12798854718454078
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.12798854718454078
ROBERTS SYNDROME	0.001301984	0.12798854718454078
2Q37 MICRODELETION SYNDROME	0.001301984	0.12798854718454078
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001301984	0.12798854718454078
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001301984	0.12798854718454078
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001301984	0.12798854718454078
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001301984	0.12798854718454078
RUVALCABA SYNDROME	0.001301984	0.12798854718454078
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001301984	0.12798854718454078
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001301984	0.12798854718454078
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.12798854718454078
SAY-BARBER-MILLER SYNDROME	0.001301984	0.12798854718454078
PELIZAEUS-MERZBACHER DISEASE	0.001301984	0.12798854718454078
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.12798854718454078
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001301984	0.12798854718454078
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.12798854718454078
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001301984	0.12798854718454078
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.12798854718454078
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.12798854718454078
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001301984	0.12798854718454078
WIEACKER-WOLFF SYNDROME	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001301984	0.12798854718454078
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.12798854718454078
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001301984	0.12798854718454078
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001301984	0.12798854718454078
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001301984	0.12798854718454078
RING CHROMOSOME 12 SYNDROME	0.001301984	0.12798854718454078
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001301984	0.12798854718454078
FILIPPI SYNDROME	0.001301984	0.12798854718454078
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001301984	0.12798854718454078
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.12798854718454078
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.12798854718454078
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001301984	0.12798854718454078
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001301984	0.12798854718454078
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.12798854718454078
CLASSIC PHENYLKETONURIA	0.001301984	0.12798854718454078
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001301984	0.12798854718454078
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001301984	0.12798854718454078
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001301984	0.12798854718454078
DISTAL MONOSOMY 15Q	0.001301984	0.12798854718454078
ALG1-CDG	0.001301984	0.12798854718454078
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.12798854718454078
ALG3-CDG	0.001301984	0.12798854718454078
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001301984	0.12798854718454078
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.12798854718454078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001301984	0.12798854718454078
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001301984	0.12798854718454078
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001301984	0.12798854718454078
17Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454078
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.12798854718454078
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.12798854718454078
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001301984	0.12798854718454078
MACDERMOT-WINTER SYNDROME	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001301984	0.12798854718454078
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.12798854718454078
HOLOPROSENCEPHALY 2; HPE2	0.001301984	0.12798854718454078
KLEEFSTRA SYNDROME 2; KLEFS2	0.001301984	0.12798854718454078
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001301984	0.12798854718454078
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001301984	0.12798854718454078
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001301984	0.12798854718454078
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001301984	0.12798854718454078
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001301984	0.12798854718454078
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.001301984	0.12798854718454078
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.12798854718454078
MUCOLIPIDOSIS IV; ML4	0.001301984	0.12798854718454078
OPTIC ATROPHY 11; OPA11	0.001301984	0.12798854718454078
NEU-LAXOVA SYNDROME	0.00075643	0.0743591140496367
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00075643	0.0743591140496367
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.0743591140496367
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.0743591140496367
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.0743591140496367
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00075643	0.0743591140496367
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.0743591140496367
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00075643	0.0743591140496367
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.0743591140496367
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00075643	0.0743591140496367
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.00075643	0.0743591140496367
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.0743591140496367
FANCONI ANEMIA	0.00075643	0.0743591140496367
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00075643	0.0743591140496367
POLAND SYNDROME	0.00075643	0.0743591140496367
LEUKOCYTE ADHESION DEFICIENCY	0.00075643	0.0743591140496367
MEIER-GORLIN SYNDROME 1; MGORS1	0.00075643	0.0743591140496367
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00075643	0.0743591140496367
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00075643	0.0743591140496367
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.0743591140496367
RENAL TUBULAR DYSGENESIS	0.00075643	0.0743591140496367
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.0743591140496367
OLIVER SYNDROME	0.00075643	0.0743591140496367
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.0743591140496367
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.0743591140496367
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.0743591140496367
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.0743591140496367
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.0743591140496367
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.0743591140496367
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.0743591140496367
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.0743591140496367
PSEUDOPROGERIA SYNDROME	0.00075643	0.0743591140496367
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.0743591140496367
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.0743591140496367
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.0743591140496367
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.0743591140496367
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.0743591140496367
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.0743591140496367
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.0743591140496367
CONGENITAL RUBELLA SYNDROME	0.00075643	0.0743591140496367
MMEP SYNDROME	0.00075643	0.0743591140496367
XK APROSENCEPHALY SYNDROME	0.00075643	0.0743591140496367
WORSTER-DROUGHT SYNDROME	0.00075643	0.0743591140496367
LAMBOTTE SYNDROME	0.00075643	0.0743591140496367
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00075643	0.0743591140496367
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.0743591140496367
3MC SYNDROME 1	0.00075643	0.0743591140496367
BANGSTAD SYNDROME	0.00075643	0.0743591140496367
MICROFORM HOLOPROSENCEPHALY	0.00075643	0.0743591140496367
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00075643	0.0743591140496367
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.0743591140496367
BOWEN-CONRADI SYNDROME	0.00075643	0.0743591140496367
WEAVER-WILLIAMS SYNDROME	0.00075643	0.0743591140496367
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.0743591140496367
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.0743591140496367
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.0743591140496367
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.0743591140496367
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.0743591140496367
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00075643	0.0743591140496367
TYROSINEMIA TYPE 2	0.00075643	0.0743591140496367
BLOOM SYNDROME	0.00075643	0.0743591140496367
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.0743591140496367
STROMME SYNDROME; STROMS	0.00075643	0.0743591140496367
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00075643	0.0743591140496367
CHARGE SYNDROME	0.00075643	0.0743591140496367
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.0743591140496367
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00075643	0.0743591140496367
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.0743591140496367
TETRAPLOIDY	0.00075643	0.0743591140496367
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.0743591140496367
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.0743591140496367
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.0743591140496367
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00075643	0.0743591140496367
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.0743591140496367
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.0743591140496367
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.0743591140496367
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.0743591140496367
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00075643	0.0743591140496367
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.0743591140496367
SATOYOSHI SYNDROME	0.00075643	0.0743591140496367
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00075643	0.0743591140496367
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.0743591140496367
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.0743591140496367
SECKEL SYNDROME 1; SCKL1	0.00075643	0.0743591140496367
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00075643	0.0743591140496367
COHEN SYNDROME	0.00075643	0.0743591140496367
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.0743591140496367
STIMMLER SYNDROME	0.00075643	0.0743591140496367
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.0743591140496367
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00075643	0.0743591140496367
HALLERMANN-STREIFF SYNDROME; HSS	0.00075643	0.0743591140496367
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.0743591140496367
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.0743591140496367
ROIFMAN SYNDROME	0.00075643	0.0743591140496367
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.0743591140496367
MOWAT-WILSON SYNDROME; MOWS	0.00075643	0.0743591140496367
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.0743591140496367
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.0743591140496367
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.0743591140496367
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.0743591140496367
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.0743591140496367
WOLF-HIRSCHHORN SYNDROME	0.00075643	0.0743591140496367
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.0743591140496367
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.0743591140496367
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.0743591140496367
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.0743591140496367
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.0743591140496367
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.0743591140496367
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.0743591140496367
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00075643	0.0743591140496367
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.0743591140496367
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.0743591140496367
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.0743591140496367
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00075643	0.0743591140496367
SECKEL SYNDROME 10; SCKL10	0.00075643	0.0743591140496367
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00075643	0.0743591140496367
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.0743591140496367
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.0743591140496367
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.0743591140496367
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00075643	0.0743591140496367
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00075643	0.0743591140496367
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.0743591140496367
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.0743591140496367
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.0743591140496367
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.0743591140496367
MENKES DISEASE	0.00075643	0.0743591140496367
BARDET-BIEDL SYNDROME 20	0.00075643	0.0743591140496367
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.0743591140496367
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.0743591140496367
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.0743591140496367
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.0743591140496367
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.0743591140496367
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00075643	0.0743591140496367
CAMOS SYNDROME	0.00075643	0.0743591140496367
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00075643	0.0743591140496367
SJÖGREN-LARSSON SYNDROME	0.00075643	0.0743591140496367
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.0743591140496367
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.0743591140496367
HYPERREFLEXIA	0.00075643	0.0743591140496367
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00075643	0.0743591140496367
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.0743591140496367
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00075643	0.0743591140496367
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.0743591140496367
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.0743591140496367
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.0743591140496367
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.0743591140496367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00075643	0.0743591140496367
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.0743591140496367
PRIMARY CUTIS VERTICIS GYRATA	0.00075643	0.0743591140496367
WARBURG MICRO SYNDROME 1	0.00075643	0.0743591140496367
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00075643	0.0743591140496367
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.0743591140496367
CYCLIC VOMITING SYNDROME	0.00075643	0.0743591140496367
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.0743591140496367
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.0743591140496367
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.0743591140496367
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00075643	0.0743591140496367
RUVALCABA SYNDROME	0.00075643	0.0743591140496367
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.0743591140496367
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00075643	0.0743591140496367
PAINE SYNDROME	0.00075643	0.0743591140496367
MICROPHTHALMIA, SYNDROMIC 1	0.00075643	0.0743591140496367
NEVUS COMEDONICUS SYNDROME	0.00075643	0.0743591140496367
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.0743591140496367
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.0743591140496367
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00075643	0.0743591140496367
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.0743591140496367
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.0743591140496367
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.0743591140496367
ANGELMAN SYNDROME	0.00075643	0.0743591140496367
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00075643	0.0743591140496367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00075643	0.0743591140496367
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.0743591140496367
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.0743591140496367
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00075643	0.0743591140496367
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.0743591140496367
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.0743591140496367
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.0743591140496367
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00075643	0.0743591140496367
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00075643	0.0743591140496367
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.0743591140496367
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00075643	0.0743591140496367
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00075643	0.0743591140496367
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00075643	0.0743591140496367
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.0743591140496367
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00075643	0.0743591140496367
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.0743591140496367
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.0743591140496367
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.0743591140496367
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00075643	0.0743591140496367
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00075643	0.0743591140496367
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.0743591140496367
15Q24 RECURRENT MICRODELETION SYNDROME	0.00075643	0.0743591140496367
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.0743591140496367
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.0743591140496367
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.0743591140496367
SECKEL SYNDROME 5; SCKL5	0.00075643	0.0743591140496367
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.0743591140496367
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.0743591140496367
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.0743591140496367
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00075643	0.0743591140496367
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00075643	0.0743591140496367
PERRAULT SYNDROME 3	0.00075643	0.0743591140496367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.0743591140496367
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00075643	0.0743591140496367
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.0743591140496367
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.0743591140496367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.0743591140496367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.0743591140496367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.0743591140496367
SECKEL SYNDROME 4	0.00075643	0.0743591140496367
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.0743591140496367
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00075643	0.0743591140496367
ANGELMAN SYNDROME (TYPE 2)	0.00075643	0.0743591140496367
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00075643	0.0743591140496367
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.0743591140496367
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.0743591140496367
ERMINE PHENOTYPE	0.00075643	0.0743591140496367
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00075643	0.0743591140496367
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.0743591140496367
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.0743591140496367
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.0743591140496367
LISSENCEPHALY 3; LIS3	0.00075643	0.0743591140496367
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.0743591140496367
FACIOCARDIOMELIC SYNDROME	0.00075643	0.0743591140496367
ANGELMAN SYNDROME (TYPE 1)	0.00075643	0.0743591140496367
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.0743591140496367
PAGOD SYNDROME	0.00075643	0.0743591140496367
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.0743591140496367
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00075643	0.0743591140496367
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.0743591140496367
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.0743591140496367
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.0743591140496367
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00075643	0.0743591140496367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.0743591140496367
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00075643	0.0743591140496367
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00075643	0.0743591140496367
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.0743591140496367
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.0743591140496367
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.0743591140496367
WAGR SYNDROME	0.00075643	0.0743591140496367
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.0743591140496367
MECKEL SYNDROME 12; MKS12	0.00075643	0.0743591140496367
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.0743591140496367
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00075643	0.0743591140496367
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.0743591140496367
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.0743591140496367
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00075643	0.0743591140496367
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.0743591140496367
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.0743591140496367
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00075643	0.0743591140496367
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.0743591140496367
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.0743591140496367
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.0743591140496367
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00075643	0.0743591140496367
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.0743591140496367
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.0743591140496367
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00075643	0.0743591140496367
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.0743591140496367
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.0743591140496367
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.0743591140496367
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.0743591140496367
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.0743591140496367
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.0743591140496367
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.0743591140496367
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00075643	0.0743591140496367
RENIER-GABREELS-JASPER SYNDROME	0.00075643	0.0743591140496367
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.0743591140496367
BRANCHIOOCULOFACIAL SYNDROME	0.00075643	0.0743591140496367
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.0743591140496367
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.0743591140496367
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00075643	0.0743591140496367
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.0743591140496367
GAUCHER DISEASE, PERINATAL LETHAL	0.00075643	0.0743591140496367
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00075643	0.0743591140496367
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.0743591140496367
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.0743591140496367
COCKAYNE SYNDROME	0.00075643	0.0743591140496367
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.0743591140496367
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.0743591140496367
SHPRINTZEN-GOLDBERG SYNDROME	0.00075643	0.0743591140496367
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.0743591140496367
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.0743591140496367
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.0743591140496367
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.0743591140496367
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.0743591140496367
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.0743591140496367
FETAL METHYLMERCURY SYNDROME	0.00075643	0.0743591140496367
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00075643	0.0743591140496367
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.0743591140496367
DIABETIC EMBRYOPATHY	0.00075643	0.0743591140496367
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.0743591140496367
FILIPPI SYNDROME; FLPIS	0.00075643	0.0743591140496367
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.0743591140496367
LOWRY-WOOD SYNDROME	0.00075643	0.0743591140496367
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.0743591140496367
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.0743591140496367
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.0743591140496367
MICROPHTHALMIA, LENZ TYPE	0.00075643	0.0743591140496367
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.0743591140496367
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00075643	0.0743591140496367
MECKEL SYNDROME	0.00075643	0.0743591140496367
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.0743591140496367
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.0743591140496367
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.0743591140496367
DISTAL TRISOMY 15Q	0.00075643	0.0743591140496367
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.0743591140496367
TRISOMY 18P	0.00075643	0.0743591140496367
VELOCARDIOFACIAL SYNDROME	0.00075643	0.0743591140496367
TRISOMY 4P	0.00075643	0.0743591140496367
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.0743591140496367
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.0743591140496367
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.0743591140496367
TEEBI-SHALTOUT SYNDROME; TBSH	0.00075643	0.0743591140496367
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.0743591140496367
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.0743591140496367
LEPRECHAUNISM	0.00075643	0.0743591140496367
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00075643	0.0743591140496367
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.0743591140496367
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00075643	0.0743591140496367
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.0743591140496367
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.0743591140496367
SANJAD-SAKATI SYNDROME	0.00075643	0.0743591140496367
KABUKI SYNDROME	0.00075643	0.0743591140496367
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00075643	0.0743591140496367
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00075643	0.0743591140496367
JUNG SYNDROME	0.00075643	0.0743591140496367
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.0743591140496367
5Q35 MICRODUPLICATION SYNDROME	0.00075643	0.0743591140496367
JUBERG-HAYWARD SYNDROME	0.00075643	0.0743591140496367
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.0743591140496367
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.0743591140496367
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.0743591140496367
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.0743591140496367
19Q13.11 MICRODELETION SYNDROME	0.00075643	0.0743591140496367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.0743591140496367
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.0743591140496367
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.0743591140496367
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.0743591140496367
FRASER SYNDROME	0.00075643	0.0743591140496367
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.0743591140496367
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00075643	0.0743591140496367
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.0743591140496367
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00075643	0.0743591140496367
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.0743591140496367
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.0743591140496367
HALLERMANN-STREIFF SYNDROME	0.00075643	0.0743591140496367
HARROD SYNDROME	0.00075643	0.0743591140496367
ADDUCTED THUMBS SYNDROME	0.00075643	0.0743591140496367
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.0743591140496367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.0743591140496367
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.0743591140496367
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.0743591140496367
NON-DISTAL TRISOMY 10Q	0.00075643	0.0743591140496367
AICARDI SYNDROME; AIC	0.00075643	0.0743591140496367
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.0743591140496367
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.0743591140496367
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00075643	0.0743591140496367
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00075643	0.0743591140496367
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.0743591140496367
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.0743591140496367
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.0743591140496367
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.0743591140496367
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00075643	0.0743591140496367
MASA SYNDROME	0.00075643	0.0743591140496367
MOYNAHAN SYNDROME	0.00075643	0.0743591140496367
SUPRABULBAR PARESIS, CONGENITAL	0.00075643	0.0743591140496367
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.0743591140496367
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.0743591140496367
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.0743591140496367
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.0743591140496367
PHENYLKETONURIA	0.00075643	0.0743591140496367
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00075643	0.0743591140496367
SCHISIS ASSOCIATION	0.00075643	0.0743591140496367
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.0743591140496367
COG5-CDG	0.00075643	0.0743591140496367
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.0743591140496367
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.0743591140496367
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00075643	0.0743591140496367
INCONTINENTIA PIGMENTI; IP	0.00075643	0.0743591140496367
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00075643	0.0743591140496367
FEINGOLD SYNDROME	0.00075643	0.0743591140496367
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.0743591140496367
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.0743591140496367
BLOOM SYNDROME	0.00075643	0.0743591140496367
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.0743591140496367
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00075643	0.0743591140496367
FOCAL DERMAL HYPOPLASIA; FDH	0.00075643	0.0743591140496367
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.0743591140496367
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00075643	0.0743591140496367
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.0743591140496367
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00075643	0.0743591140496367
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00075643	0.0743591140496367
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.0743591140496367
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.0743591140496367
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00075643	0.0743591140496367
DISTAL MONOSOMY 7Q36	0.00075643	0.0743591140496367
DISTAL MONOSOMY 17Q	0.00075643	0.0743591140496367
DISTAL MONOSOMY 13Q	0.00075643	0.0743591140496367
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.0743591140496367
MENTAL RETARDATION, X-LINKED 102	0.00075643	0.0743591140496367
ANE SYNDROME	0.00075643	0.0743591140496367
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00075643	0.0743591140496367
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00075643	0.0743591140496367
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00075643	0.0743591140496367
ROBERTS SYNDROME; RBS	0.00075643	0.0743591140496367
CRANIOFRONTONASAL DYSPLASIA	0.00075643	0.0743591140496367
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.0743591140496367
RING CHROMOSOME 1 SYNDROME	0.00075643	0.0743591140496367
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.0743591140496367
RHIZOMELIC SYNDROME	0.00075643	0.0743591140496367
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.0743591140496367
OTOMANDIBULAR SYNDROME	0.00075643	0.0743591140496367
ZEBRA BODY MYOPATHY	0.000545554	0.053629433134904085
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.053629433134904085
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.053629433134904085
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.053629433134904085
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.053629433134904085
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000545554	0.053629433134904085
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.053629433134904085
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.053629433134904085
COG2-CDG	0.000545554	0.053629433134904085
RIGID SPINE SYNDROME	0.000545554	0.053629433134904085
THYROID ECTOPIA	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.053629433134904085
TRANSKETOLASE DEFICIENCY	0.000545554	0.053629433134904085
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.053629433134904085
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.053629433134904085
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.053629433134904085
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.053629433134904085
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.053629433134904085
ALSTROM SYNDROME; ALMS	0.000545554	0.053629433134904085
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.053629433134904085
ATHYREOSIS	0.000545554	0.053629433134904085
DISTAL MONOSOMY 19P13.3	0.000545554	0.053629433134904085
AUSTRALIA ANTIGEN	0.000545554	0.053629433134904085
ARGININOSUCCINIC ACIDURIA	0.000545554	0.053629433134904085
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.053629433134904085
ANGELMAN SYNDROME	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.053629433134904085
THYROID HYPOPLASIA	0.000545554	0.053629433134904085
RECOMBINANT 8 SYNDROME	0.000545554	0.053629433134904085
THYROID HEMIAGENESIS	0.000545554	0.053629433134904085
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.053629433134904085
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.053629433134904085
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.053629433134904085
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.053629433134904085
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.053629433134904085
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.053629433134904085
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.053629433134904085
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.053629433134904085
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.053629433134904085
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.053629433134904085
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.053629433134904085
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.053629433134904085
8P23.1 DUPLICATION SYNDROME	0.000545554	0.053629433134904085
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.053629433134904085
HURLER SYNDROME	0.000545554	0.053629433134904085
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.053629433134904085
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.053629433134904085
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.053629433134904085
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.053629433134904085
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.053629433134904085
6Q TERMINAL DELETION SYNDROME	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.053629433134904085
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.053629433134904085
INFANTILE REFSUM DISEASE	0.000545554	0.053629433134904085
DIGEORGE SYNDROME; DGS	0.000545554	0.053629433134904085
MEDULLOBLASTOMA	0.000545554	0.053629433134904085
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.053629433134904085
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.053629433134904085
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.053629433134904085
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.053629433134904085
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.053629433134904085
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.053629433134904085
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.053629433134904085
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.053629433134904085
WOLMAN DISEASE	0.000545554	0.053629433134904085
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.053629433134904085
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.053629433134904085
CURRARINO SYNDROME	0.000545554	0.053629433134904085
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.053629433134904085
NARP SYNDROME	0.000545554	0.053629433134904085
ALSTRÖM SYNDROME	0.000545554	0.053629433134904085
LEBER CONGENITAL AMAUROSIS	0.000545554	0.053629433134904085
SEPTOOPTIC DYSPLASIA	0.000545554	0.053629433134904085
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.053629433134904085
PALLISTER-HALL SYNDROME	0.000545554	0.053629433134904085
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000545554	0.053629433134904085
3C SYNDROME	0.000545554	0.053629433134904085
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.053629433134904085
PRADER-WILLI SYNDROME; PWS	0.000545554	0.053629433134904085
NETHERTON SYNDROME	0.000545554	0.053629433134904085
CHAR SYNDROME	0.000545554	0.053629433134904085
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.053629433134904085
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.053629433134904085
PELGER-HUET ANOMALY; PHA	0.000545554	0.053629433134904085
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.053629433134904085
CHAR SYNDROME	0.000545554	0.053629433134904085
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.053629433134904085
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.053629433134904085
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.053629433134904085
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.053629433134904085
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.053629433134904085
TREACHER-COLLINS SYNDROME	0.000545554	0.053629433134904085
SIALIDOSIS TYPE 2	0.000545554	0.053629433134904085
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.053629433134904085
COACH SYNDROME	0.000545554	0.053629433134904085
MAPLE SYRUP URINE DISEASE	0.000545554	0.053629433134904085
ARGININEMIA	0.000545554	0.053629433134904085
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.053629433134904085
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.053629433134904085
ATELOSTEOGENESIS TYPE III	0.000545554	0.053629433134904085
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.053629433134904085
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.053629433134904085
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.053629433134904085
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.053629433134904085
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.053629433134904085
PFEIFFER SYNDROME TYPE 2	0.000545554	0.053629433134904085
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.053629433134904085
CONGENITAL HYPOTHYROIDISM	0.000545554	0.053629433134904085
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.053629433134904085
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.053629433134904085
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.053629433134904085
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.053629433134904085
ALG6-CDG	0.000545554	0.053629433134904085
CRANIOPHARYNGIOMA	0.000545554	0.053629433134904085
WYBURN-MASON SYNDROME	0.000545554	0.053629433134904085
PALLISTER-HALL SYNDROME	0.000545554	0.053629433134904085
SCHIZENCEPHALY	0.000545554	0.053629433134904085
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.053629433134904085
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.053629433134904085
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.053629433134904085
SYNDROMIC DIARRHEA	0.000545554	0.053629433134904085
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.053629433134904085
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.053629433134904085
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.053629433134904085
KEUTEL SYNDROME	0.000545554	0.053629433134904085
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.053629433134904085
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.053629433134904085
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.053629433134904085
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.053629433134904085
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.053629433134904085
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.053629433134904085
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.053629433134904085
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.053629433134904085
JOUBERT SYNDROME 26	0.000545554	0.053629433134904085
JOUBERT SYNDROME 25	0.000545554	0.053629433134904085
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.053629433134904085
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.053629433134904085
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.053629433134904085
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.053629433134904085
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.053629433134904085
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.053629433134904085
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.053629433134904085
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.053629433134904085
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.053629433134904085
SENIOR-LOKEN SYNDROME 9	0.000545554	0.053629433134904085
NOONAN SYNDROME 2; NS2	0.000545554	0.053629433134904085
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.053629433134904085
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.053629433134904085
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.053629433134904085
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.053629433134904085
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.053629433134904085
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.053629433134904085
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.053629433134904085
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000545554	0.053629433134904085
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.053629433134904085
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.053629433134904085
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.053629433134904085
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000545554	0.053629433134904085
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.053629433134904085
AU-KLINE SYNDROME; AUKS	0.000545554	0.053629433134904085
NOONAN SYNDROME 9; NS9	0.000545554	0.053629433134904085
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.053629433134904085
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.053629433134904085
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.053629433134904085
HURLER SYNDROME	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.053629433134904085
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.053629433134904085
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.053629433134904085
LISSENCEPHALY 1; LIS1	0.000545554	0.053629433134904085
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.053629433134904085
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.053629433134904085
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.053629433134904085
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.053629433134904085
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.053629433134904085
CHOPS SYNDROME; CHOPS	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.053629433134904085
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000545554	0.053629433134904085
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.053629433134904085
PHACE ASSOCIATION	0.000545554	0.053629433134904085
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.053629433134904085
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.053629433134904085
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.053629433134904085
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.053629433134904085
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.053629433134904085
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.053629433134904085
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.053629433134904085
SOTOS SYNDROME	0.000545554	0.053629433134904085
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.053629433134904085
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.053629433134904085
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.053629433134904085
MECKEL SYNDROME 13; MKS13	0.000545554	0.053629433134904085
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.053629433134904085
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.053629433134904085
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.053629433134904085
RAHMAN SYNDROME	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.053629433134904085
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000545554	0.053629433134904085
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.053629433134904085
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.053629433134904085
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.053629433134904085
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.053629433134904085
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.053629433134904085
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.053629433134904085
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.053629433134904085
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.053629433134904085
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.053629433134904085
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.053629433134904085
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.053629433134904085
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.053629433134904085
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.053629433134904085
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.053629433134904085
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.053629433134904085
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.053629433134904085
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.053629433134904085
JOUBERT SYNDROME 28	0.000545554	0.053629433134904085
JOUBERT SYNDROME 27	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.053629433134904085
MEIER-GORLIN SYNDROME 7	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.053629433134904085
MIRAGE SYNDROME; MIRAGE	0.000545554	0.053629433134904085
MUENKE SYNDROME	0.000545554	0.053629433134904085
CDAGS SYNDROME	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.053629433134904085
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.053629433134904085
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.053629433134904085
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.053629433134904085
SHASHI-PENA SYNDROME; SHAPNS	0.000545554	0.053629433134904085
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.053629433134904085
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.053629433134904085
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.053629433134904085
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.053629433134904085
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.053629433134904085
CURRY-JONES SYNDROME	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.053629433134904085
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.053629433134904085
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.053629433134904085
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.053629433134904085
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.053629433134904085
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.053629433134904085
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.053629433134904085
JOUBERT SYNDROME 15	0.000545554	0.053629433134904085
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.053629433134904085
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.053629433134904085
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.053629433134904085
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.053629433134904085
JOUBERT SYNDROME 6	0.000545554	0.053629433134904085
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.053629433134904085
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.053629433134904085
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.053629433134904085
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.053629433134904085
HOLOPROSENCEPHALY 7	0.000545554	0.053629433134904085
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.053629433134904085
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.053629433134904085
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.053629433134904085
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.053629433134904085
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.053629433134904085
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.053629433134904085
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.053629433134904085
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.053629433134904085
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.053629433134904085
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000545554	0.053629433134904085
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.053629433134904085
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.053629433134904085
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.053629433134904085
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.053629433134904085
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.053629433134904085
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.053629433134904085
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.053629433134904085
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.053629433134904085
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.053629433134904085
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.053629433134904085
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.053629433134904085
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.053629433134904085
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.053629433134904085
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.053629433134904085
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.053629433134904085
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.053629433134904085
JOUBERT SYNDROME 8	0.000545554	0.053629433134904085
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.053629433134904085
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000545554	0.053629433134904085
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.053629433134904085
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.053629433134904085
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.053629433134904085
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.053629433134904085
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.053629433134904085
JOUBERT SYNDROME 7	0.000545554	0.053629433134904085
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.053629433134904085
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.053629433134904085
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.053629433134904085
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.053629433134904085
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.053629433134904085
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.053629433134904085
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.053629433134904085
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.053629433134904085
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.053629433134904085
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.053629433134904085
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.053629433134904085
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.053629433134904085
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.053629433134904085
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.053629433134904085
KAGAMI-OGATA SYNDROME	0.000545554	0.053629433134904085
CULLER-JONES SYNDROME; CJS	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.053629433134904085
XIA-GIBBS SYNDROME	0.000545554	0.053629433134904085
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.053629433134904085
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000545554	0.053629433134904085
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.053629433134904085
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.053629433134904085
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.053629433134904085
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.053629433134904085
JOUBERT SYNDROME 2	0.000545554	0.053629433134904085
HELSMOORTEL-VAN DER AA SYNDROME	0.000545554	0.053629433134904085
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 2	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.053629433134904085
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.053629433134904085
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.053629433134904085
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.053629433134904085
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.053629433134904085
JOUBERT SYNDROME 21	0.000545554	0.053629433134904085
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.053629433134904085
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.053629433134904085
STEEL SYNDROME; STLS	0.000545554	0.053629433134904085
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.053629433134904085
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.053629433134904085
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.053629433134904085
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.053629433134904085
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.053629433134904085
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.053629433134904085
FRIAS SYNDROME	0.000545554	0.053629433134904085
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.053629433134904085
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.053629433134904085
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.053629433134904085
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.053629433134904085
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.053629433134904085
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.053629433134904085
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.053629433134904085
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.053629433134904085
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.053629433134904085
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.053629433134904085
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.053629433134904085
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.053629433134904085
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.053629433134904085
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.053629433134904085
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.053629433134904085
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.053629433134904085
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.053629433134904085
OGDEN SYNDROME	0.000545554	0.053629433134904085
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.053629433134904085
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.053629433134904085
OTOFACIOCERVICAL SYNDROME	0.000545554	0.053629433134904085
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.053629433134904085
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.053629433134904085
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.053629433134904085
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.053629433134904085
W SYNDROME	0.000545554	0.053629433134904085
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.053629433134904085
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.053629433134904085
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.053629433134904085
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.053629433134904085
OROTIC ACIDURIA	0.000545554	0.053629433134904085
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.053629433134904085
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.053629433134904085
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.053629433134904085
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.053629433134904085
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.053629433134904085
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.053629433134904085
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.053629433134904085
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.053629433134904085
ELEJALDE DISEASE	0.000545554	0.053629433134904085
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.053629433134904085
TARP SYNDROME	0.000545554	0.053629433134904085
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.053629433134904085
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.053629433134904085
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.053629433134904085
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.053629433134904085
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.053629433134904085
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.053629433134904085
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.053629433134904085
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.053629433134904085
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.053629433134904085
PELLAGRA-LIKE SYNDROME	0.000545554	0.053629433134904085
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.053629433134904085
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.053629433134904085
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.053629433134904085
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.053629433134904085
SULFOCYSTEINURIA	0.000545554	0.053629433134904085
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.053629433134904085
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.053629433134904085
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.053629433134904085
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.053629433134904085
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.053629433134904085
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.053629433134904085
USHER SYNDROME TYPE 1	0.000545554	0.053629433134904085
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.053629433134904085
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.053629433134904085
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.053629433134904085
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.053629433134904085
CITRULLINEMIA TYPE II	0.000545554	0.053629433134904085
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.053629433134904085
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.053629433134904085
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.053629433134904085
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.053629433134904085
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.053629433134904085
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.053629433134904085
3MC SYNDROME 2	0.000545554	0.053629433134904085
N SYNDROME	0.000545554	0.053629433134904085
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.053629433134904085
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.053629433134904085
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.053629433134904085
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.053629433134904085
17Q12 MICRODELETION SYNDROME	0.000545554	0.053629433134904085
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.053629433134904085
1P21.3 MICRODELETION SYNDROME	0.000545554	0.053629433134904085
HEREDITARY OROTIC ACIDURIA	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.053629433134904085
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.053629433134904085
GAUCHER DISEASE, TYPE II	0.000545554	0.053629433134904085
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.053629433134904085
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.053629433134904085
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000545554	0.053629433134904085
HARTNUP DISORDER	0.000545554	0.053629433134904085
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.053629433134904085
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.053629433134904085
ISOLATED PLAGIOCEPHALY	0.000545554	0.053629433134904085
PROPIONIC ACIDEMIA	0.000545554	0.053629433134904085
FUCOSIDOSIS	0.000545554	0.053629433134904085
WILSON-TURNER SYNDROME	0.000545554	0.053629433134904085
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.053629433134904085
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.053629433134904085
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.053629433134904085
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.053629433134904085
DYSTONIA-APHONIA SYNDROME	0.000545554	0.053629433134904085
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.053629433134904085
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.053629433134904085
MEND SYNDROME	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.053629433134904085
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.053629433134904085
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.053629433134904085
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.053629433134904085
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.053629433134904085
GRISCELLI SYNDROME	0.000545554	0.053629433134904085
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.053629433134904085
HYPERPROLINEMIA, TYPE I	0.000545554	0.053629433134904085
WEAVER SYNDROME	0.000545554	0.053629433134904085
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.053629433134904085
SEVERE CANAVAN DISEASE	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.053629433134904085
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.053629433134904085
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.053629433134904085
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.053629433134904085
SENIOR-LOKEN SYNDROME	0.000545554	0.053629433134904085
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.000545554	0.053629433134904085
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.053629433134904085
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.053629433134904085
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.053629433134904085
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.053629433134904085
JAWAD SYNDROME	0.000545554	0.053629433134904085
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.053629433134904085
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.053629433134904085
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.053629433134904085
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.053629433134904085
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.053629433134904085
LANDAU-KLEFFNER SYNDROME	0.000545554	0.053629433134904085
KETOADIPICACIDURIA	0.000545554	0.053629433134904085
SRD5A3-CDG	0.000545554	0.053629433134904085
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.053629433134904085
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.053629433134904085
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.000545554	0.053629433134904085
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.053629433134904085
ARIMA SYNDROME	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.053629433134904085
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.053629433134904085
FARBER DISEASE	0.000545554	0.053629433134904085
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.053629433134904085
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.053629433134904085
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.053629433134904085
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.053629433134904085
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.053629433134904085
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.053629433134904085
WAISMAN SYNDROME; WSMN	0.000545554	0.053629433134904085
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.053629433134904085
TARP SYNDROME; TARPS	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.053629433134904085
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.053629433134904085
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.053629433134904085
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.053629433134904085
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.053629433134904085
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.053629433134904085
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.053629433134904085
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.053629433134904085
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.053629433134904085
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.053629433134904085
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.053629433134904085
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.053629433134904085
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.053629433134904085
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.053629433134904085
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.053629433134904085
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.053629433134904085
TRANSALDOLASE DEFICIENCY	0.000545554	0.053629433134904085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.053629433134904085
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.053629433134904085
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.053629433134904085
NOONAN SYNDROME 11; NS11	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.053629433134904085
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.053629433134904085
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.053629433134904085
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.053629433134904085
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.053629433134904085
TIMOTHY SYNDROME; TS	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.053629433134904085
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.053629433134904085
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.053629433134904085
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.053629433134904085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.053629433134904085
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.053629433134904085
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.053629433134904085
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.053629433134904085
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.053629433134904085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.053629433134904085
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.053629433134904085
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.053629433134904085
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.053629433134904085
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.053629433134904085
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.053629433134904085
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.053629433134904085
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.053629433134904085
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.053629433134904085
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.053629433134904085
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.053629433134904085
CODAS SYNDROME	0.000545554	0.053629433134904085
BAND HETEROTOPIA; BH	0.000545554	0.053629433134904085
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.053629433134904085
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.053629433134904085
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.053629433134904085
AYMÉ-GRIPP SYNDROME	0.000545554	0.053629433134904085
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.053629433134904085
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.053629433134904085
EAST SYNDROME	0.000545554	0.053629433134904085
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.053629433134904085
COLE-CARPENTER SYNDROME	0.000545554	0.053629433134904085
FLOATING-HARBOR SYNDROME	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.053629433134904085
COWDEN SYNDROME	0.000545554	0.053629433134904085
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.053629433134904085
OCCIPITAL HORN SYNDROME	0.000545554	0.053629433134904085
TRISOMY 8Q	0.000545554	0.053629433134904085
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.053629433134904085
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.053629433134904085
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.053629433134904085
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.053629433134904085
TEMTAMY SYNDROME	0.000545554	0.053629433134904085
GERODERMA OSTEODYSPLASTICA	0.000545554	0.053629433134904085
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.053629433134904085
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.053629433134904085
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000545554	0.053629433134904085
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.053629433134904085
HARTNUP DISEASE	0.000545554	0.053629433134904085
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.053629433134904085
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.053629433134904085
DONNAI-BARROW SYNDROME	0.000545554	0.053629433134904085
ZECHI-CEIDE SYNDROME	0.000545554	0.053629433134904085
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.053629433134904085
HYDRANENCEPHALY	0.000545554	0.053629433134904085
WAARDENBURG-SHAH SYNDROME	0.000545554	0.053629433134904085
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.053629433134904085
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.053629433134904085
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.053629433134904085
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.053629433134904085
DYSKERATOSIS CONGENITA	0.000545554	0.053629433134904085
DISTAL TRISOMY 6P	0.000545554	0.053629433134904085
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.053629433134904085
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.053629433134904085
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.053629433134904085
CINCA SYNDROME	0.000545554	0.053629433134904085
XQ21 MICRODELETION SYNDROME	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.053629433134904085
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.053629433134904085
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.053629433134904085
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.053629433134904085
AURICULOCONDYLAR SYNDROME	0.000545554	0.053629433134904085
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.053629433134904085
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.053629433134904085
MEND SYNDROME; MEND	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.053629433134904085
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.053629433134904085
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.053629433134904085
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.053629433134904085
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.053629433134904085
DEXTROCARDIA	0.000545554	0.053629433134904085
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.053629433134904085
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.053629433134904085
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.053629433134904085
MOSAIC TRISOMY 14	0.000545554	0.053629433134904085
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.053629433134904085
DISTAL TRISOMY 18Q	0.000545554	0.053629433134904085
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.053629433134904085
